Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,47028,0.034031205035545,0.0134418512970358,0.0076851764933549,0.0603772335777351,0.0113582129565492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,45177,0.0182056313878849,0.0149382361747182,-0.0110733115145628,0.0474845742903326,0.222965180021439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1070.Time spent watching television (TV),47754,0.0148682408433589,0.0132584679444203,-0.011118356327705,0.0408548380144228,0.262125441483503
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1080.Time spent using computer,45161,-0.00817913023015034,0.0134451452269581,-0.0345316148749882,0.0181733544146875,0.5429747500359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X1090.Time spent driving,42910,0.00112550034775775,0.0147513952388393,-0.0277872343203673,0.0300382350158828,0.939183170285313
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1160.Sleep duration,48657,0.0027759027397831,0.0121935511039602,-0.021123457423979,0.0266752629035452,0.819918063126904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34727,0.0171083526241242,0.0448042803947648,-0.0707080369496148,0.104924742197863,0.702588550909993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34727,-0.000938853212115836,0.0498637218292304,-0.0986717479974075,0.0967940415731758,0.98497862519299
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34727,0.000742775409074941,0.0527030485783221,-0.102555199804436,0.104040750622586,0.988755769461938
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34727,0.0324810183731181,0.05454948266889,-0.0744359676579063,0.139398004404143,0.551570474874068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34727,0.0199900242280467,0.0551862295897111,-0.0881749857677871,0.128155034223881,0.717193789068986
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34727,-0.180430353096536,0.149098330437662,-0.472663080754354,0.111802374561281,0.226270575376533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34727,0.00725564524520074,0.186104509338522,-0.357509193058302,0.372020483548704,0.968902071671262
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34727,-0.0544606508856901,0.0888936283796564,-0.228692162509817,0.119770860738437,0.540130754363127
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34727,0.00296619250447355,0.0691349931790117,-0.132538394126389,0.138470779135337,0.965779172744585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34727,0.0499589607174429,0.0455965699789973,-0.0394103164413918,0.139328237876278,0.273264679220886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34727,0.153194661406065,0.0724367937685732,0.0112185456196614,0.295170777192469,0.034480989661051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34727,-0.0171359563162165,0.0341801915690654,-0.0841291317915847,0.0498572191591518,0.616148654143798
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34727,-0.087870609046506,0.0461801870223452,-0.178383775610302,0.0026425575172906,0.0571164491669902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34727,0.0688728919753607,0.0732365725974166,-0.0746707903155758,0.212416574266297,0.347040960472441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34727,-0.0642500131218762,0.0678486570640172,-0.19723338096735,0.0687333547235974,0.343696140036589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34727,0.00432489030108308,0.0828278335426471,-0.158017663442505,0.166667444044671,0.958358746739501
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34727,0.121871721804373,0.0824553337653372,-0.0397407323756875,0.283484175984434,0.139450290678382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34727,-0.00732866259821511,0.0521577122674197,-0.109557778642358,0.0949004534459275,0.88826193672797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34727,-0.0565320936241838,0.0510432852338977,-0.156576932682623,0.0435127454342556,0.268107276949023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34727,0.0356845184559629,0.0566226306070737,-0.0752958375339015,0.146664874445827,0.528576420418397
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120040.Fatigue severity over the past week,34735,0.016097758268271,0.0228853707565437,-0.0287575684145546,0.0609530849510967,0.481828077194142
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34738,0.00855862110952151,0.0224972490158724,-0.0355359869615884,0.0526532291806314,0.703639659266719
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34737,0.0351627244711283,0.0248613755588411,-0.0135655716242002,0.0838910205664569,0.157309461386387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120098.Mobility problems today,34739,-0.0545621457685786,0.0266011927380681,-0.106700483535192,-0.00242380800196499,0.0402979720648866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120099.Self-care problems today,34739,-0.0684833303642895,0.0401269632744458,-0.147132178382203,0.0101655176536243,0.0879347180680356
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120100.Problems doing usual activities,34739,-0.0233524975264738,0.025563063635088,-0.0734561022512464,0.0267511071982988,0.361002387875388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120101.Pain or discomfort today,34739,-0.0150879329027265,0.0225513518164943,-0.0592885824630552,0.0291127166576023,0.503490140936216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120102.Anxiety or depression today,34739,0.0359493455168726,0.0289660698676162,-0.0208241514236551,0.0927228424574003,0.214621913850735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120103.Scale to indicate how health is today,34725,0.0217444092532221,0.0147669271457464,-0.00719876795244089,0.0506875864588851,0.140935295832864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34724,-0.0210387225353464,0.0284077543470845,-0.076717921055632,0.0346404759849392,0.458965698899826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34722,-0.00793552873521933,0.0300576210032566,-0.0668484659016022,0.0509774084311636,0.791780686810623
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34727,0.0182301689053174,0.0230279536292123,-0.0269046202079386,0.0633649580185734,0.428593175462617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34732,-0.00613595463089282,0.023311339526852,-0.0518261801035228,0.0395542708417371,0.792391719690781
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34732,-0.0157809985694831,0.0336274512847435,-0.0816908030875804,0.0501288059486142,0.638879648643866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34720,-0.00573294152437547,0.0319200782996803,-0.0682962949917488,0.0568304119429979,0.857470204494051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34736,0.00406157678342437,0.0304679826992076,-0.0556556693070226,0.0637788228738713,0.893955447135808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34730,-0.040965340159972,0.0457427657132666,-0.130621160957974,0.0486904806380305,0.370523579741035
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34698,-0.0589361391021365,0.0614563362875007,-0.179390558225638,0.0615182800213648,0.337600773074497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32400,-0.0043738602138309,0.0324247389623268,-0.0679263485799914,0.0591786281523297,0.892703868327607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46461,0.0342115183341473,0.0295347278561936,-0.0236765482639922,0.0920995849322867,0.246737188501988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45431,0.0504236819514108,0.017039484886,0.0170262915748508,0.0838210723279707,0.00308842532510967
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1289.Cooked vegetable intake,47844,0.0188568151184753,0.0127476835890284,-0.00612864471602034,0.043842274952971,0.139093984261421
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47144,-0.00248184050622773,0.0131345922146602,-0.0282256412469618,0.0232619602345063,0.85013053394904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1309.Fresh fruit intake,47743,-0.00705678045324122,0.0134905487683614,-0.0334982560392296,0.0193846951327471,0.600917199199621
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1319.Dried fruit intake,46891,-0.0148337049569946,0.0142637510989839,-0.0427906571110031,0.0131232471970139,0.298373066841831
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X134.Number of self-reported cancers,48782,-0.0481733999015995,0.0269268268648484,-0.100949980556702,0.00460318075350348,0.0736219944451734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48783,-0.0100637944079533,0.0126978007016236,-0.0349514837831355,0.0148238949672289,0.428042367877278
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X136.Number of operations, self-reported",48783,-0.00161611714325009,0.0122304921680523,-0.0255878817926325,0.0223556475061323,0.894876174464763
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X137.Number of treatments or medications taken,48783,-0.0216008581377548,0.0124509251603342,-0.0460046714520099,0.00280295517650027,0.0827773700858593
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1438.Bread intake,48322,0.00974921034645951,0.00784297899899904,-0.00562302849157861,0.0251214491844976,0.2138644072244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1458.Cereal intake,47748,-0.00339914047403613,0.0127115889124957,-0.0283138547425277,0.0215155737944554,0.789160348911778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1488.Tea intake,48031,0.010028326262036,0.00773608223517475,-0.00513439491890645,0.0251910474429786,0.19488563598587
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1498.Coffee intake,47217,0.0126029996131045,0.0126947825532711,-0.0122787741913069,0.037484773417516,0.320834943487808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X1528.Water intake,47004,-0.0202065874215635,0.0129057521415838,-0.0455018616190678,0.00508868677594079,0.117435129334136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1568.Average weekly red wine intake,43980,-0.0390229124955547,0.0139781026130521,-0.0664199936171368,-0.0116258313739727,0.00524937980217565
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43981,-0.0153062763978547,0.0145843234794935,-0.043891550417662,0.0132789976219525,0.293963634314401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,44034,-0.0105246610203577,0.0145314880491055,-0.0390063775966044,0.017957055555889,0.468913497100454
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1598.Average weekly spirits intake,43977,-0.0154602978828818,0.0151201511486962,-0.0450957941343263,0.0141751983685628,0.306562172112185
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,44009,0.033161943703576,0.0269209035531901,-0.0196030272606767,0.0859269146678286,0.218031849940222
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,43446,-0.025662494090078,0.0149815918877646,-0.0550264141900966,0.00370142600994057,0.0867453671131482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1807.Father's age at death,43609,0.0130664983936168,0.00884698543701501,-0.00427359306293262,0.0304065898501662,0.139711740982388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1845.Mother's age,36064,0.0203385675937017,0.0204486666782603,-0.0197408190956885,0.0604179542830919,0.319955387390243
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1873.Number of full brothers,48441,0.0212346323430837,0.0122757845868168,-0.00282590544707726,0.0452951701332447,0.0836818556627042
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X1883.Number of full sisters,48442,-0.000907429078355905,0.0122847690897744,-0.0249855764943137,0.0231707183376019,0.941117604029579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20015.Sitting height,48604,-0.0205164461014839,0.0101025426926067,-0.0403174297789931,-0.00071546242397472,0.0422864519695607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20016.Fluid intelligence score,35142,-0.00462241193081136,0.0198843495981697,-0.043595737143224,0.0343509132816013,0.816184286482998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20018.Prospective memory result,35441,-0.00272396718493885,0.0267096217092295,-0.0550748257350287,0.049626891365151,0.918771974389723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35054,-0.00762643033508133,0.0138685415882758,-0.034808771848102,0.0195559111779393,0.582401091728395
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35056,0.0045419648677939,0.0138347894221634,-0.0225742223996464,0.0316581521352342,0.742695299908436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20023.Mean time to correctly identify matches,48534,-0.00725721927232337,0.00793832052022504,-0.0228163274919644,0.00830188894731771,0.360622381335929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45848,0.0137339881944412,0.0177679160055915,-0.0210911271765182,0.0485591035654005,0.439553320486162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45475,-0.0674485961102754,0.0395902023318333,-0.145045392680669,0.0101482004601179,0.0884613748188889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45442,-0.0405140486582849,0.0520119658015282,-0.14245750162928,0.0614294043127104,0.436027725140941
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45460,0.0553413760919798,0.0471654194895725,-0.0371028461075822,0.147785598291542,0.240673489894917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45484,0.0799159613101421,0.0312678902945165,0.0186308963328899,0.141201026287394,0.010601629977535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,45625,0.0302032203876679,0.0226172507605492,-0.0141265911030085,0.0745330318783444,0.181761239493597
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45583,-0.0037314069397349,0.028768001572436,-0.0601166900217094,0.0526538761422396,0.896799896871218
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45489,-0.00703489808634725,0.0349713638882548,-0.0755787713073266,0.0615089751346321,0.84057458141702
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45609,-0.00042019015345263,0.0268922474216591,-0.0531289950999044,0.0522886147929992,0.987533780231568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45678,0.0264611575652697,0.0201325079971836,-0.0129985581092102,0.0659208732397496,0.188746172336588
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45553,-0.0121712679675075,0.027565736152937,-0.066200110827264,0.0418575748922491,0.65883055548672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46491,-0.000600291372098525,0.0211527291228841,-0.0420596404529514,0.0408590577087543,0.977360262239029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46361,0.00201996602708279,0.0296888264633773,-0.0561701338411366,0.0602100658953022,0.94575621356244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46292,-0.027021943615883,0.0670663244367007,-0.158471939511816,0.10442805228005,0.687016551456211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46323,0.0910281821027163,0.0350344449617463,0.0223606699776936,0.159695694227739,0.00937782874518233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46442,0.00430889082470014,0.0238347986654299,-0.0424073145595426,0.0510250962089428,0.856541132434735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46361,0.00959586627802767,0.0400010235089321,-0.0688061397994792,0.0879978723555345,0.810417899645143
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46329,-0.0314044697667149,0.0359230716757501,-0.101813690251185,0.0390047507177554,0.382013298375385
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46338,0.0375103873269716,0.0306532391113107,-0.0225699613311974,0.0975907359851406,0.221081444869811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46367,-0.0340111558145003,0.0358557351885582,-0.104288396784074,0.0362660851550739,0.342859620225398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46545,-0.0112312615480215,0.0181586316922219,-0.0468221796647763,0.0243596565687334,0.536248282801079
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46414,0.00214433680949703,0.0274035030589925,-0.0515665291861283,0.0558552028051223,0.93762970002921
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43912,0.0163215105588397,0.0290861252106775,-0.0406872948540883,0.0733303159717676,0.574707448035029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43786,-0.100399892149499,0.118728251451263,-0.333107264993976,0.132307480694977,0.397773819699274
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43782,0.0488084457778602,0.11583534164632,-0.178228823848927,0.275845715404648,0.673497771031098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43832,-0.0571301114216527,0.0378042120197937,-0.131226366980448,0.016966144137143,0.13075564477745
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43792,0.00867125238633038,0.0679010700830134,-0.124414844976376,0.141757349749037,0.898384750005032
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43823,0.00461588065772793,0.0486998590904768,-0.0908358431596065,0.100067604475062,0.924489058797281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43799,0.0650775878055092,0.0555991409189942,-0.0438967283957195,0.174051904006738,0.2418268945432
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43805,-0.047288129478499,0.0544087860934889,-0.153929350221737,0.0593530912647393,0.384791545170586
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43809,-0.0388521946428429,0.0426871293407003,-0.122518968150616,0.0448145788649298,0.362751608306614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43825,-0.0347995472910652,0.0544398846476187,-0.141501721200398,0.0719026266182675,0.522683654459327
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43967,0.000457013779227501,0.0221728937423895,-0.0430018579558558,0.0439158855143108,0.983555935802842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43886,-0.0509672226500176,0.0306770589952404,-0.111094258280689,0.00915981298065346,0.0966513098112647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20127.Neuroticism score,44830,-0.00947125128977194,0.012709393065906,-0.0343816616989476,0.0154391591194038,0.456151559271557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35142,-0.00107924661239269,0.0201007067300246,-0.040476631803241,0.0383181385784556,0.957182220023691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20161.Pack years of smoking,35702,-0.0069468479949421,0.013267264754174,-0.032950686913123,0.0190569909232388,0.600567447160118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35702,-0.00748813825353866,0.0130762415283882,-0.0331175716491794,0.0181412951421021,0.566898347743151
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20191.Fluid intelligence score,33266,0.0326723641656697,0.0238605667368305,-0.014094346638518,0.0794390749698575,0.170970409706461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33267,0.0258093167553659,0.0242266785063114,-0.0216749731170044,0.0732936066277363,0.286783567260216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X20240.Maximum digits remembered correctly,32833,-0.0506265783696688,0.0255796610328001,-0.100762713993957,-0.000490442745380543,0.0478613330551585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X20255.Spirometry QC measure,42978,0.0248811548918398,0.0155819297718311,-0.00565942746094911,0.0554217372446287,0.110333278950536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20261.avMSE,33123,-0.0196475598242957,0.0168593015811207,-0.0526917909232922,0.0133966712747008,0.243925056703635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X20262.Myopia diagnosis,33123,0.0220677616234485,0.0307103899471757,-0.0381246026730159,0.0822601259199129,0.472439081386317
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20280.Glucose-lactate,39735,0.0787159575249943,0.0100740930253484,0.0589707351953114,0.0984611798546772,6.05256759483371e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39754,0.0853548469695549,0.0106890976941007,0.0644042154891175,0.106305478449992,1.54031692818167e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,34827,0.0702801663333761,0.065471705034269,-0.058044375533791,0.198604708200543,0.283113839105459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,34827,0.0879271219493414,0.141827735905835,-0.190055240426095,0.365909484324778,0.535308669267521
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),34830,0.278139693022708,0.169872185095286,-0.0548097897640532,0.611089175809469,0.101608514159231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),34830,0.0887218367803063,0.0639376627781699,-0.0365959822649067,0.214039655825519,0.165299285114644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),34830,-0.0107394684963616,0.0891192228134374,-0.185413145210699,0.163934208217976,0.904085613618136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,34831,0.216347326313352,0.123423473518058,-0.0255626817820417,0.458257334408746,0.0796706858014331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,34831,0.146581484829665,0.079211422041231,-0.00867290237114759,0.301835872030478,0.0642874600100465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,34831,0.14677256225294,0.0897047519629092,-0.0290487515943624,0.322593876100242,0.101853728652163
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,34831,0.0779441037556495,0.132233039728029,-0.181232654111287,0.337120861622586,0.555584169498395
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,34831,0.0520796439962818,0.145536122105308,-0.233171155330122,0.337330443322685,0.720470042763876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,34831,0.184072782981836,0.0951425309127657,-0.00240657760718452,0.370552143570857,0.0530716469721176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,34831,0.157127467095511,0.140665033376204,-0.118575998321849,0.432830932512871,0.264023337408578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,34831,-0.0150652093270129,0.110453465479969,-0.231554001667753,0.201423583013727,0.891514084437212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),34834,0.397194546282228,0.186209670374058,0.0322235923490737,0.762165500215383,0.0329595665507808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),34834,0.105953477573765,0.0857719819790936,-0.0621596071052582,0.274066562252789,0.216768252230287
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),34834,0.0848391270111256,0.107972357037636,-0.12678669278264,0.296464946804891,0.432044655113448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,34834,0.0985331334916112,0.226509206244775,-0.345424910748149,0.542491177731371,0.663572266245001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,35253,-0.0289463424418127,0.019863023414052,-0.0678778683333545,0.00998518344972915,0.145081424762227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20601.Liking for aniseed,35253,0.00920371474947456,0.0197534141630577,-0.0295129770101186,0.0479204065090677,0.641280645189974
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20602.Liking for apple juice,35253,0.0221423970786393,0.0197953807215965,-0.0166565491356899,0.0609413432929685,0.263366697254681
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20603.Liking for apples,35253,-0.0173273000471401,0.0202702845281342,-0.0570570577222831,0.0224024576280029,0.392685575301345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20604.Liking for asparagus,35253,-0.00537084442649129,0.0199767429793721,-0.0445252606660607,0.0337835718130781,0.788049723043823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20605.Liking for aubergine,35253,-0.0514036059251446,0.0199397820927326,-0.0904855788269004,-0.0123216330233887,0.00996040320562201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20606.Liking for avocados,35253,-0.0117200848196942,0.0198565325361449,-0.0506388885905382,0.0271987189511498,0.555051012036853
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20607.Liking for bacon,35253,-0.0220468629441771,0.0202102137083693,-0.0616588818125809,0.0175651559242266,0.27536644517369
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35253,0.0155171865932724,0.0200055834000709,-0.0236937568708666,0.0547281300574114,0.437987532729579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20609.Liking for bananas,35253,0.0137303741658845,0.0204136475782741,-0.0262803750875328,0.0537411234193017,0.501220366961176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35253,-0.0469401239243585,0.0201006731846248,-0.086337443366223,-0.00754280448249391,0.019559908012917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20611.Liking for beef steak,35253,-0.0167633676255432,0.0202051961674212,-0.0563655521136889,0.0228388168626024,0.406762961556487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20612.Liking for beetroot,35253,0.00997168768173991,0.0200833344514487,-0.0293916478430996,0.0493350232065794,0.619547151401835
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20613.Liking for bell pepper,35253,-0.0179892788562342,0.0199218773321127,-0.0570361584271751,0.0210576007147068,0.366563329965728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20614.Liking for bicycling,35253,0.0407933651480756,0.0199159791285493,0.00175804605611905,0.0798286842400321,0.0405724600545969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20615.Liking for biscuits,35253,0.0377877738178761,0.0201238538389664,-0.00165497970649816,0.0772305273422503,0.060457731879805
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20616.Liking for bitter foods,35253,-0.0231820536805804,0.0198790682881012,-0.0621450275252588,0.0157809201640979,0.243594072386584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20617.Liking for bitter or ale,35253,-0.0216458106243689,0.0200662157765426,-0.0609755935463924,0.0176839722976545,0.280752119811616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20618.Liking for black olives,35253,-0.00725178227739629,0.0199132310265492,-0.0462817150894327,0.0317781505346401,0.715743371145118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20619.Liking for black pepper,35253,-0.0570834209839389,0.0201616963346989,-0.0966003457999487,-0.0175664961679292,0.004650136288752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20620.Liking for blue cheese,35253,0.0102233680339833,0.0198746072148723,-0.0287308621071663,0.0491775981751329,0.606994037839528
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,35253,-0.0240217915667736,0.0201618824277531,-0.0635390811251696,0.0154954979916224,0.233521153268408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20622.Liking for broad beans,35253,-0.00990807686207914,0.019880463688165,-0.0488737856908825,0.0290576319667243,0.618230907246684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20623.Liking for broccoli,35253,0.0273842451731921,0.0200645746891834,-0.0119423212176073,0.0667108115639915,0.172360355180678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20624.Liking for brown rice,35253,-0.00132697446382322,0.0198982200789668,-0.0403274858185982,0.0376735368909518,0.946832015671111
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,35253,0.0148525212853738,0.0201267304963364,-0.0245958704874456,0.0543009130581932,0.460570880675262
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20626.Liking for burgers (meat),35253,-0.0242694717952562,0.0199080060784195,-0.0632891637089585,0.014750220118446,0.22285673282692
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35253,-0.0542330571863422,0.0198938695357326,-0.0932250414763782,-0.0152410728963063,0.00642519075346596
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20628.Liking for butter on bread,35253,-0.00679618697992663,0.0202029394311301,-0.0463939482649416,0.0328015743050883,0.736582927752619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20629.Liking for butternut squash,35253,-0.0262290143298807,0.0197512310382182,-0.0649414271647884,0.012483398505027,0.184234103908816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20630.Liking for cabbage,35253,0.00329880486684357,0.0200111874576736,-0.0359231225501966,0.0425207322838837,0.869068612224621
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20631.Liking for cake,35253,0.0277180898616042,0.0201429696708743,-0.0117621306933095,0.067198310416518,0.168847055126277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20632.Liking for cake icing,35253,0.0294381967652664,0.0198008166682614,-0.00937140390452594,0.0682477974350588,0.137137208805375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20633.Liking for capers,35253,-0.0170365636051031,0.0199700307549922,-0.0561778238848877,0.0221046966746815,0.39363098490186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20634.Liking for cauliflower,35253,0.0151856854615332,0.0201218119086597,-0.0242530658794398,0.0546244368025062,0.450463092050495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35253,0.0169030417933971,0.0199243501537299,-0.0221486845079135,0.0559547680947077,0.396267513025533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20636.Liking for cheesecake,35253,0.0418407577597349,0.0199400139939021,0.0027583303316867,0.0809231851877831,0.035913541825791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20637.Liking for cherries,35253,0.0108150173663148,0.0202864731862186,-0.0289464700786736,0.0505765048113032,0.593972004876302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20638.Liking for chicken,35253,-0.0249018997867674,0.0206240589144304,-0.0653250552590511,0.0155212556855162,0.227313444870734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20639.Liking for chilli pepper,35253,-0.0383541274515285,0.0199295460605749,-0.0774160377302553,0.000707782827198203,0.0543363812085787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20640.Liking for chips or french fries,35253,-0.000269679037275708,0.0201443945961282,-0.039752692445687,0.0392133343711356,0.989319201672715
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,35253,-0.00187467513130277,0.0314565149111517,-0.0635294443571602,0.0597800940945546,0.952479382236718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20642.Liking for cod,35253,0.0100869164541064,0.020542369709265,-0.030176128176053,0.0503499610842659,0.623421562701221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,35253,0.0152239852567062,0.0207885470305264,-0.0255215669231255,0.0559695374365379,0.463995687545823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,35253,-0.0064879000540816,0.0201746369979777,-0.046030188570118,0.0330543884619548,0.747775745011496
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20645.Liking for coriander,35253,-0.00302278244343304,0.0198799448884986,-0.0419874744248903,0.0359419095380242,0.879150655651536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20646.Liking for corn flakes,35253,0.020389027316202,0.0199034506050432,-0.0186217358696827,0.0593997905020867,0.305685278104557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20647.Liking for cream,35253,0.012668048194572,0.0198846046245376,-0.0263057768695217,0.0516418732586658,0.52409585570467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20648.Liking for croissant,35253,-0.022503028101615,0.0199626103047041,-0.0616297442988351,0.0166236880956052,0.259673785720873
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20649.Liking for cucumber,35253,0.00786023032406412,0.0199376132608389,-0.03121749166718,0.0469379523153083,0.693415558869067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20650.Liking for curry,35253,-0.0175296518687479,0.0202798666549837,-0.0572781905125161,0.0222188867750202,0.387406570798722
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20651.Liking for dairy products,35253,0.0177045704795023,0.0202779955447485,-0.0220403007882047,0.0574494417472092,0.382644089694846
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20652.Liking for dark chocolate,35253,-0.013698479720463,0.0201197361375227,-0.0531331625500075,0.0257362031090815,0.495991476048799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35253,0.0264614375107425,0.0202717382266723,-0.0132711694135352,0.0661940444350202,0.191823530506971
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20654.Liking for dried fruit,35253,0.00114313100746475,0.0200897974263845,-0.0382328719482489,0.0405191339631784,0.954625711512585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20655.Liking for eggs,35253,-0.00128450458496221,0.0205707755740633,-0.0416032247101263,0.0390342155402019,0.95021178989166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20656.Liking for exercising alone,35253,0.0435555594068462,0.0198169167374953,0.00471440260135553,0.0823967162123369,0.0279907604729664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20657.Liking for exercising with others,35253,0.0487771846736847,0.0197634865381543,0.0100407510589023,0.0875136182884671,0.0136103058389918
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35253,-0.000289939010803289,0.0200095456850581,-0.0395086485535172,0.0389287705319106,0.988439464676061
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20659.Liking for fatty foods,35253,-0.0505951138942326,0.019914155471729,-0.0896268586188213,-0.0115633691696438,0.0110868808544084
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35253,-0.000295638592680409,0.0206316256469363,-0.0407336248606757,0.0401423476753148,0.988567623129346
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20661.Liking for fried chicken,35253,-0.0303658499178792,0.0199427455006651,-0.0694536310991829,0.00872193126342446,0.127893527213368
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,35253,0.000394320235334278,0.020076769144739,-0.0389561472883541,0.0397447877590226,0.984330648110531
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20663.Liking for fruit,35253,0.0120047956951069,0.0211034005921301,-0.0293578694654682,0.0533674608556819,0.569473106510001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20664.Liking for garlic,35253,-0.0273133771342996,0.0201243051786939,-0.0667570152845396,0.0121302610159404,0.17475319520214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20665.Liking for gherkins,35253,-0.0221858239005198,0.0198492090588317,-0.06109027365583,0.0167186258547904,0.263727744909119
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20666.Liking for globe artichoke,35253,-0.0104164191913035,0.0199717848171651,-0.0495611174329471,0.0287282790503401,0.601996367494557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20667.Liking for goat's cheese,35253,-0.00522131315315717,0.0198176316343959,-0.0440638711565732,0.0336212448502589,0.792198001446447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20668.Liking for going to a cafe,35253,-0.00416971535137309,0.0200168745291928,-0.043402789428591,0.0350633587258448,0.834993300772628
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20669.Liking for going to the gym,35253,0.0207564219289241,0.0197804292726474,-0.0180132194454648,0.059526063303313,0.294059218867878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20670.Liking for going to the pub,35253,-0.00670546718535564,0.0199681849063751,-0.0458431096018508,0.0324321752311395,0.737026602383877
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20671.Liking for grapefruit,35253,0.0322118529929185,0.0200124232593318,-0.00701249659537188,0.071436202581209,0.107534282349684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20672.Liking for green olives,35253,-0.000346035619037238,0.01990118818631,-0.0393523644642048,0.0386602932261303,0.986127854601823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20673.Liking for haddock,35253,-0.0180806707538117,0.0204312051859491,-0.058125832918272,0.0219644914106485,0.376213624727766
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20674.Liking for ham,35253,0.0180846340346159,0.0202888225508572,-0.0216814581650642,0.057850726234296,0.372768634094851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20675.Liking for hard cheese,35253,0.000257908004100519,0.0202733927624427,-0.0394779418102872,0.0399937578184883,0.989850365794268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20676.Liking for herring,35253,0.00232193023066822,0.0199293629116489,-0.0367396210761636,0.0413834815375,0.907253466859272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20677.Liking for honey,35253,0.00747098407686695,0.0199655466562158,-0.031661487369316,0.0466034555230499,0.708272066174261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35253,-0.0162742541198923,0.0198868603461339,-0.0552525003983147,0.0227039921585302,0.413191248429788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20679.Liking for ice cream,35253,0.0295537959851367,0.0200879063519053,-0.00981850046459757,0.0689260924348711,0.141278095730595
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20680.Liking for jam,35253,0.0587327248649849,0.0200719196295842,0.0193917623909998,0.09807368733897,0.00344387743355791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,35253,-0.00109234996363056,0.0199497114464808,-0.0401937843987329,0.0380090844714718,0.956335157404509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20682.Liking for lager,35253,-0.0595987685141848,0.0199889913694206,-0.098777191598249,-0.0204203454301205,0.00287805665800611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20683.Liking for lamb,35253,0.00406476940456683,0.0202709556197176,-0.0356663036100797,0.0437958424192134,0.841078613235618
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20684.Liking for lemons,35253,-0.00669314595100514,0.0199787691537307,-0.0458515334923172,0.0324652415903069,0.737625910246518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20685.Liking for lentils or beans,35253,-0.000813284903759766,0.0201272639751859,-0.040262722295124,0.0386361524876045,0.967769762777106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20686.Liking for liver,35253,0.0329562378223029,0.0198586374605053,-0.00596669160028752,0.0718791672448932,0.0970538714636696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20687.Liking for mackerel,35253,0.0217873801043999,0.0200158932395031,-0.0174437706450261,0.061018530853826,0.2764121481043
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20688.Liking for marzipan,35253,0.0418885376855496,0.0198001241204937,0.00308029440938191,0.0806967809617174,0.0344185525364009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20689.Liking for mayonnaise,35253,-0.044642013011123,0.0200502520081818,-0.0839405069471593,-0.00534351907508674,0.0260136842933606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20690.Liking for melon,35253,-0.0183488406390636,0.0202043549533876,-0.0579493763477032,0.021251695069576,0.363825230487341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20691.Liking for milk chocolate,35253,0.0445220144335344,0.0200421631702095,0.00523937461992383,0.083804654247145,0.0263562622236991
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20692.Liking for mushrooms,35253,6.01640290237699e-05,0.0203912004546833,-0.0399065888621555,0.0400269169202031,0.997645941735098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20694.Liking for orange juice,35253,-0.00641856214010942,0.0199540285785771,-0.0455284581541206,0.0326913338739018,0.74771473380947
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20695.Liking for oranges,35253,0.0216693170722675,0.0201895925594723,-0.0179022843442983,0.0612409184888333,0.283179350056896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20696.Liking for pasta,35253,0.00199487689751213,0.0201805020421151,-0.0375589071050336,0.0415486609000578,0.921259002371802
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20697.Liking for pears,35253,-0.0170012003060293,0.0202186839063043,-0.0566298207623858,0.0226274201503272,0.400453366636983
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20698.Liking for pizza,35253,-0.0244428084812756,0.0199896472741415,-0.063622517138593,0.0147369001760418,0.221458675725981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20699.Liking for plain yogurt,35253,0.00309045028454036,0.0197885622360949,-0.0356951316982056,0.0418760322672863,0.875900958962297
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20700.Liking for plums,35253,-0.00137893300696874,0.0201963422317492,-0.0409637637811972,0.0382058977672597,0.945567685957991
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20701.Liking for pollock,35253,0.0105547296280402,0.0199360303809281,-0.0285198899185788,0.0496293491746593,0.596524982425377
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20702.Liking for pork chop,35253,-0.0282704444669126,0.0199917977075037,-0.06745436797362,0.0109134790397947,0.157378762910949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20703.Liking for porridge,35253,0.0282846114323213,0.0199964801611646,-0.0109084896835614,0.0674777125482039,0.157268019956214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20704.Liking for potato crisps,35253,-0.00414775352206863,0.0201054771249313,-0.0435544886869341,0.0352589816427968,0.836563148714681
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20705.Liking for potatoes,35253,0.0132197014407839,0.0203485663757525,-0.026663488655691,0.0531028915372587,0.515932677970605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20706.Liking for prawns,35253,-0.027365611494468,0.0201605217756732,-0.0668802341747874,0.0121490111858515,0.174704675488593
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20707.Liking for raw carrots,35253,0.00344819323010896,0.0199215267946361,-0.0355979992873779,0.0424943857475958,0.862586898505027
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20708.Liking for red meat,35253,-0.0537986771303337,0.0202385542274196,-0.0934662434160761,-0.0141311108445913,0.00787410602970548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20709.Liking for red wine,35253,-0.0435529972131921,0.0201667351780469,-0.083079798162164,-0.00402619626422012,0.0308357938113575
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35253,0.0394972339251438,0.0201775064255296,-5.06786688942093e-05,0.0790451465191818,0.0503318837414612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20711.Liking for roast chicken,35253,-0.0172188041662139,0.0206995890163865,-0.0577899986383313,0.0233523903059036,0.405527575501553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20712.Liking for salad dressing,35253,-0.0287086680019965,0.0200319503673695,-0.0679712907220407,0.0105539547180478,0.151863762750773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20713.Liking for salad leaves,35253,-0.0189716279952764,0.0200382970026244,-0.0582466901204202,0.0203034341298674,0.34379119819436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20714.Liking for salami,35253,-0.0459651233961429,0.0199795422694377,-0.0851250262442409,-0.00680522054804498,0.0214445432348018
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20715.Liking for salmon,35253,-0.011627609435306,0.0203805509260221,-0.0515734892503094,0.0283182703796973,0.568341110187513
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20716.Liking for salty foods,35253,-0.0266875215226053,0.0198309587930682,-0.065556200757019,0.0121811577118084,0.178428933495797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20717.Liking for salty pretzels,35253,-0.0304460139512668,0.0198692191972145,-0.0693896835778072,0.00849765567527364,0.125490950693457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20718.Liking for sardines,35253,0.00739507223619586,0.0199371348365598,-0.0316817120434614,0.0464718565158531,0.710709310750103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20719.Liking for sausages (meat),35253,-0.0224063946932421,0.0200931797624544,-0.0617890270276527,0.0169762376411685,0.264837456836279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,35253,-0.0234929476590343,0.0201723571038336,-0.0630307675825483,0.0160448722644796,0.24421833015698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35253,-0.0116439300134086,0.0198555570096322,-0.0505608217522877,0.0272729617254704,0.557605303217761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20722.Liking for skimmed milk,35253,0.00974316543494225,0.0199012530440646,-0.0292632905314245,0.0487496214013089,0.624450496744476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20723.Liking for smoked fish,35253,0.0143116579084987,0.0199685788444906,-0.0248267566267029,0.0534500724437003,0.473578933913106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20724.Liking for soft cheese,35253,0.0179012107124334,0.0199277932540296,-0.0211572640654647,0.0569596854903315,0.369056204499607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20725.Liking for soy sauce,35253,-0.0392052385634653,0.0199908235158762,-0.0783872526545827,-2.32244723479408e-05,0.0499018630562538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20726.Liking for soya milk,35253,-0.00136492469281172,0.0200835036637814,-0.0407285918738232,0.0379987424881997,0.94581754781924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20727.Liking for spicy foods,35253,-0.0224028965645904,0.0200801744457657,-0.0617600384782911,0.0169542453491104,0.264602735761897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20728.Liking for spinach,35253,-0.00438497791321483,0.0198282207463021,-0.043248290575967,0.0344783347495373,0.824983735326424
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20729.Liking for spirits,35253,0.00458381398536873,0.0199681839108486,-0.0345538264798945,0.043721454450632,0.818443961960352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20730.Liking for strawberries,35253,0.00343188290406724,0.0205818295385687,-0.0369085029915274,0.0437722687996619,0.867577080333075
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35253,0.0280928551271951,0.0201163610099808,-0.0113352124523673,0.0675209227067575,0.162605290169647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20732.Liking for sweet foods,35253,0.0479270560701946,0.019845580784705,0.00902971773217293,0.0868243944082163,0.015762085776697
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20733.Liking for taking the stairs,35253,0.0411529263829177,0.0203193843564467,0.00132693304428214,0.0809789197215533,0.0428760806517191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20734.Liking for tea with sugar,35253,0.0205587691443657,0.0218841356401459,-0.0223341367103202,0.0634516749990516,0.347540518402058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20735.Liking for tea without sugar,35253,-0.00289047181313815,0.0203941808633793,-0.0428630663053616,0.0370821226790853,0.887297398113855
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,35253,0.0248901357569118,0.0199661576309662,-0.014243533199782,0.0640238047136056,0.212582202897492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20737.Liking for tinned tuna,35253,-0.00932508586626127,0.0200358945796071,-0.0485954392422911,0.0299452675097686,0.641646690509146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20738.Liking for turnip (white),35253,0.00132178066209147,0.0199214452203825,-0.0377242519698583,0.0403678132940412,0.947101461847718
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20739.Liking for vegetables,35253,0.019194695346219,0.0206505598142001,-0.0212804018896131,0.0596697925820511,0.352663793969302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20740.Liking for vinegar,35253,-0.0107819162755282,0.019934637149105,-0.0498538050877741,0.0282899725367177,0.588619849145591
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20741.Liking for watching television,35253,-0.0274907523669028,0.0201155088191307,-0.066917149652399,0.0119356449185934,0.171782961075888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20742.Liking for whisky,35253,0.0185488622259443,0.0199896576976826,-0.0206308668615135,0.0577285913134022,0.353481244288766
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20743.Liking for white bread,35253,0.0135898710887655,0.0198315341777668,-0.0252799358996575,0.0524596780771886,0.493200148937103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20744.Liking for white rice,35253,0.00435237028572891,0.0202095300374805,-0.0352583085877329,0.0439630491591907,0.829491493587743
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20745.Liking for white wine,35253,-0.00716193804911364,0.0200437417974105,-0.0464476719720382,0.0321237958738109,0.720867035181122
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35253,0.0288630221408929,0.0200860091554976,-0.0105055558038824,0.0682316000856683,0.150773188154873
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20747.Liking for whole milk,35253,0.0390767852268305,0.0197407261197596,0.000384962032101775,0.0777686084215592,0.0478008461443584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,35253,-0.0153484519957097,0.0205591307774097,-0.0556443483194327,0.0249474443280133,0.455360688063398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X20749.Liking for working up a sweat,35253,0.0331778674197346,0.020030459978266,-0.00608183413766667,0.0724375689771359,0.0976939873080546
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21001.Body mass index (BMI),48662,0.0353334001340631,0.0405511605392672,-0.0441468745229006,0.114813674791027,0.38358499427723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21002.Weight,48688,-0.0578749957588161,0.0195077111362062,-0.0961101095857803,-0.0196398819318518,0.00301295110826441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,35427,0.0139167697134049,0.0148050933079972,-0.0151012131702695,0.0429347525970794,0.347251440910922
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35085,-0.0431275556088928,0.0221619617744668,-0.0865650006868477,0.000309889469062054,0.0516958630665042
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35088,-0.0275529423259981,0.0225729742189918,-0.071795971795222,0.0166900871432259,0.222275677139861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35089,-0.00532090617769557,0.0218823775494445,-0.0482103661746068,0.0375685538192157,0.807889593062157
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21040.Satisfaction with bowel habits,35065,-0.0410934481183666,0.0202950298961088,-0.0808717067147399,-0.00131518952199328,0.0429286221921335
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35061,-0.0466426177879952,0.0221232757120473,-0.0900042381836079,-0.00328099739238238,0.0350430515151544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,35060,0.00530770177380365,0.0220836600966825,-0.037976272015694,0.0485916755633014,0.810070282276405
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21043.Least number of times bowels opened per week,35034,-0.0115265607771801,0.0220264491378904,-0.0546984010874453,0.0316452795330852,0.600779736658447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21044.Average number of times bowels opened per day,35043,0.0136939072614065,0.0240525339645799,-0.03344905930917,0.060836873831983,0.569149879975516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35092,0.000836628459243675,0.0220702075381255,-0.0424209783154823,0.0440942352339697,0.969762524270749
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35087,-0.0152485801457893,0.0220958790270968,-0.058556503038899,0.0280593427473205,0.49014990399166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35091,-0.00593476930874392,0.0255692955259305,-0.0560505885395676,0.0441810499220798,0.816463537520584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35091,0.016864829334306,0.0320546062066335,-0.0459621988306955,0.0796918574993076,0.598817177672813
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35090,0.018467161691706,0.0270723200242263,-0.0345945855557775,0.0715289089391895,0.495173625574211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35088,-0.0328882327723375,0.0638788619051032,-0.15809080210634,0.0923143365616648,0.606673188186271
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35092,0.0469947938132037,0.0275195915464253,-0.0069436056177898,0.100933193244197,0.0877426245264415
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35090,0.0270131266771041,0.0251839968912724,-0.0223475072297898,0.076373760583998,0.283476760487276
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34965,-0.00314048547605842,0.0250569421677368,-0.0522520921248225,0.0459711211727057,0.900263137253792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35088,-0.014465268453238,0.0226601667191547,-0.0588791952227813,0.0299486583163053,0.523264067901436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35091,0.0638640386255497,0.0389313625071617,-0.0124414318884872,0.140169509139587,0.10096498008653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35092,0.00943726151814656,0.0222027706308847,-0.0340801689183875,0.0529546919546806,0.670815173563376
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35092,0.00401120950100165,0.0221882683622856,-0.0394777964890782,0.0475002154910815,0.856545398527036
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X21100.Water hardness (USGS classification),48550,0.0178556437652885,0.0124230006514224,-0.0064934375114995,0.0422047250420764,0.150646969352123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,46159,-0.00731909033829785,0.0079984589566867,-0.0229960698934038,0.00835788921680809,0.360171353751557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2149.Lifetime number of sexual partners,44703,0.0022485163356872,0.0140616220613695,-0.025312262904597,0.0298092955759714,0.872958326691406
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22032.IPAQ activity group,45450,-0.00473788439746752,0.013430708827864,-0.0310620737000809,0.0215863049051459,0.724269015405551
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22033.Summed days activity,45786,0.0023399009582161,0.00796894887691282,-0.013279238840533,0.0179590407569652,0.769046256623253
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22034.Summed minutes activity,45450,0.00286645981959182,0.00805503281841417,-0.0129214045045,0.0186543241436836,0.721950254421192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22037.MET minutes per week for walking,44852,-0.00467872533257802,0.00824300073694431,-0.0208350067769889,0.0114775561118328,0.570314602955884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22038.MET minutes per week for moderate activity,45450,0.00874582943373347,0.00817484440348544,-0.00727686559709799,0.0247685244645649,0.284703690703061
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,45450,-0.00819841922906184,0.0132585029386202,-0.0341850849887574,0.0177882465306337,0.53635181804247
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,44852,0.00406407233079803,0.00815393554152764,-0.0119176413305961,0.0200457859921922,0.618195844205088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,45493,-0.00871533472151179,0.00830999394993918,-0.0250029228633926,0.007572253420369,0.294295537063466
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X22501.Year ended full time education,33237,-0.0292763942361321,0.0371374169152675,-0.102065731390056,0.0435129429177921,0.430546295785255
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X22506.Tobacco smoking,33205,0.0800911065545677,0.0503923276503187,-0.0186778556400569,0.178860068749192,0.112049801746554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47522,-0.021055459656549,0.0385307387981945,-0.0965757077010103,0.0544647883879123,0.584757073541679
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23098.Weight,48310,-0.0515344538877172,0.0197404182614559,-0.0902256736801708,-0.0128432340952635,0.00904503594063878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23099.Body fat percentage,48279,0.0569507094915883,0.0176760232640243,0.0223057038941006,0.091595715089076,0.00127542388092763
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23100.Whole body fat mass,48241,0.0278260282889997,0.0176852998485687,-0.00683715941419506,0.0624892159921944,0.115642628279898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23101.Whole body fat-free mass,48306,-0.0580756673024426,0.0170722770402558,-0.0915373303013439,-0.0246140043035412,0.000670881526546302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23102.Whole body water mass,48310,-0.0603199614283939,0.0170286186988784,-0.0936960540781956,-0.0269438687785921,0.000397615686084137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23104.Body mass index (BMI),48310,0.041743940746307,0.0401305023868373,-0.036911843931894,0.120399725424508,0.29825752680482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23105.Basal metabolic rate,48310,-0.0621360210161649,0.0177230943821417,-0.0968732860051627,-0.0273987560271671,0.000456017034444189
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23106.Impedance of whole body,48310,0.0353656858481198,0.0139612666515298,0.00800160321112142,0.0627297684851181,0.0113126291028671
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23107.Impedance of leg (right),48310,0.0439630863933142,0.0112964067292145,0.0218221292040538,0.0661040435825746,9.9840380046487e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23108.Impedance of leg (left),48310,0.0510213477598832,0.0112417729642294,0.0289874727499936,0.0730552227697727,5.69770631910394e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23109.Impedance of arm (right),48310,-0.00377042475943269,0.0138575570694314,-0.0309312366155182,0.0233903870966529,0.785559993087346
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23110.Impedance of arm (left),48310,0.0010780323848093,0.0138376169059815,-0.0260436967509144,0.028199761520533,0.937903674781316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23111.Leg fat percentage (right),48310,0.0767200689013752,0.0179701265051561,0.0414986209512693,0.111941516851481,1.96994004697964e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23112.Leg fat mass (right),48310,0.0507016282690144,0.0193508718038428,0.0127739195334824,0.0886293370045463,0.00879659220543997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23113.Leg fat-free mass (right),48309,-0.0792880025581401,0.0187256581294318,-0.115990292491827,-0.0425857126244537,2.30415780222341e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23114.Leg predicted mass (right),48309,-0.0811504010114864,0.0188641784443782,-0.118124190762468,-0.0441766112605051,1.70212165789822e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23115.Leg fat percentage (left),48309,0.0929103423660218,0.0187728279986172,0.0561155994887321,0.129705085243311,7.51367274284892e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23116.Leg fat mass (left),48309,0.0588593092987956,0.0204957658128894,0.0186876083055324,0.0990310102920588,0.00408603498823439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23117.Leg fat-free mass (left),48308,-0.090262323392406,0.0203541861723312,-0.130156528290175,-0.0503681184946369,9.27495534253361e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23118.Leg predicted mass (left),48308,-0.0922794224906255,0.0205155353031946,-0.132489871684887,-0.052068973296364,6.89787183226075e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23119.Arm fat percentage (right),48308,0.00919787912938569,0.0198740152213422,-0.0297551907044451,0.0481509489632165,0.643506172373993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23120.Arm fat mass (right),48307,-0.025529058920657,0.0216987841293426,-0.0680586758141686,0.0170005579728545,0.239401256291213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23121.Arm fat-free mass (right),48306,-0.0376334276662727,0.0187081498780712,-0.0743014014272922,-0.000965453905253176,0.044275067352841
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23122.Arm predicted mass (right),48306,-0.0342663054733202,0.0188021508549509,-0.0711185211490239,0.00258591020238359,0.0683992554149205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23123.Arm fat percentage (left),48304,0.013683387608283,0.0186788806274607,-0.02292721842154,0.0502939936381059,0.463835979636086
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23124.Arm fat mass (left),48304,-0.0264948138816731,0.0207840930263338,-0.0672316362132873,0.0142420084499411,0.20240781285547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23125.Arm fat-free mass (left),48300,-0.034698322981278,0.0170494262254008,-0.0681151983830635,-0.00128144757949243,0.0418480596802554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23126.Arm predicted mass (left),48299,-0.0341593348578387,0.0171401197467513,-0.0677539695614712,-0.000564700154206253,0.04628112081608
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23127.Trunk fat percentage,48298,0.037520402411107,0.0149671480059225,0.00818479231949899,0.0668560125027151,0.0121892096625028
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23128.Trunk fat mass,48298,0.0201407646459903,0.0157695251624997,-0.0107675046725092,0.0510490339644898,0.201548332455488
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23129.Trunk fat-free mass,48297,-0.0443605866918246,0.0148223718571747,-0.073412435531887,-0.0153087378517621,0.00276761744776671
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X23130.Trunk predicted mass,48295,-0.0464216419763291,0.0148259003259304,-0.0754804066151527,-0.0173628773375056,0.00174396967945415
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23400.Total Cholesterol,39757,0.107174613244228,0.0107002790496809,0.0862020663068538,0.128147160181603,1.62851411490835e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39757,0.122238997192975,0.0104212939774968,0.101813260997081,0.142664733388869,1.37518214249799e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39757,0.126409299948956,0.0104675986911027,0.105892806514395,0.146925793383518,2.27639553786621e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23403.VLDL Cholesterol,39757,0.153973901445868,0.0107200603419599,0.132962583175627,0.174985219716109,2.28128581326571e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39757,0.0977543170008692,0.0104186141889244,0.0773338331905773,0.118174800811161,7.67587425550511e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23405.LDL Cholesterol,39757,0.113550088507275,0.0103507246708524,0.0932626681524038,0.133837508862145,7.37116216898871e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23406.HDL Cholesterol,39757,-0.0184785422782242,0.0118750550154682,-0.0417536501085419,0.00479656555209347,0.119717300365796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23407.Total Triglycerides,39757,0.176888314271558,0.0108388569126411,0.155644154722781,0.198132473820335,3.45073544084786e-59
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,39757,0.175762066911575,0.0109904647317201,0.154220756037403,0.197303377785746,6.20136680631723e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23409.Triglycerides in LDL,39757,0.162180249434629,0.0102658146807801,0.1420592526603,0.182301246208958,1.28281796222166e-55
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23410.Triglycerides in HDL,39757,0.153537881108945,0.0106597781420601,0.132644715950507,0.174431046267382,1.28738006072169e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39757,0.13056500925777,0.0107237541520865,0.10954645111968,0.151583567395859,6.90087053516774e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,39757,0.172797084866277,0.010788864864271,0.151650909732306,0.193943260000248,4.25316368265201e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23413.Phospholipids in LDL,39757,0.113871834891053,0.0103912541528948,0.0935049767513796,0.134238693030727,8.38875349536249e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23414.Phospholipids in HDL,39757,0.0329989822787716,0.0113439419422122,0.0107648560720356,0.0552331084855076,0.00363358330479758
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,39757,0.102034203864202,0.0107650304701694,0.0809347441426698,0.123133663585734,3.10628343428418e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39757,0.139857098877503,0.0106898337510549,0.118905024725435,0.16080917302957,7.92889848235726e-39
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39757,0.124155318938247,0.0103355032015812,0.103897732663147,0.144412905213346,4.88210523676869e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39757,-0.0306402891497316,0.0118741996326397,-0.0539137204297054,-0.0073668578697578,0.00988100109725371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23419.Total Free Cholesterol,39757,0.117997898181629,0.0105504261452825,0.0973190629368749,0.138676733426382,6.94076421412949e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39757,0.167216145341712,0.01075883622766,0.146128826335498,0.188303464347926,6.58996280514706e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,39757,0.0814395869504434,0.0104341446791741,0.0609886633792621,0.101890510521625,6.4763082582134e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,39757,0.022980858127072,0.0118033654455976,-0.00015373814629931,0.0461154544004434,0.0515627839846151
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39757,0.148368630547669,0.0102666550137635,0.128245986720692,0.168491274374645,6.49947145704587e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,39757,0.177209584493297,0.0107803237706281,0.156080149902866,0.198339019083728,5.15635277380964e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23425.Total Lipids in LDL,39757,0.120869863351123,0.0103488662827198,0.100586085436992,0.141153641265254,2.46768093678556e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23426.Total Lipids in HDL,39757,0.0235808228616398,0.0115445383628943,0.000953527670366879,0.0462081180529127,0.0411159452909774
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39757,0.0753652822820139,0.0109581430795765,0.053887321846044,0.0968432427179839,6.4142096730444e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,39757,0.163872864269994,0.0106713133683361,0.142957090068056,0.184788638471933,1.10823508191748e-52
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,39757,0.119281647891273,0.0103890220854014,0.0989191646038862,0.13964413117866,2.41877203760026e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,39757,0.0579984199543988,0.0109678873721005,0.0365013607050818,0.0794954792037158,1.25983968789238e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39757,0.153058363776285,0.0111870872870678,0.131131672693632,0.174985054858938,2.86273805885678e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39757,-0.0468477416951881,0.0107580359663425,-0.0679334921892195,-0.0257619912011567,1.34453918508922e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39757,-0.0769914289451808,0.011783459607321,-0.10008700977553,-0.0538958481148317,6.68888035704715e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23434.Phosphoglycerides,39747,0.125238657385137,0.0107518838456354,0.104164965047691,0.146312349722582,3.55659659101965e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39747,0.146866919165375,0.0114768401667208,0.124372312438602,0.169361525892148,3.12170100031783e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23436.Total Cholines,39747,0.121302001914373,0.010946808429892,0.0998462573917849,0.142757746436962,2.18105209669784e-28
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23437.Phosphatidylcholines,39747,0.111902147159506,0.0109939038969631,0.0903540955214587,0.133450198797554,3.15444889232836e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23438.Sphingomyelins,39747,0.096810828307084,0.0110824918159227,0.0750891443478756,0.118532512266292,2.77258567470068e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23439.Apolipoprotein B,39757,0.123033322466948,0.0104285080330707,0.102593446722129,0.143473198211766,6.20136840063617e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23440.Apolipoprotein A1,39757,0.041046289222045,0.0112980160530323,0.0189021777581017,0.0631904006859883,0.000281344720291198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39757,0.0892540204968348,0.0106350637576782,0.0684092955317855,0.110098745461884,5.3360407705869e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23442.Total Fatty Acids,39747,0.164192044070676,0.00995717628899382,0.144675978544248,0.183708109597104,2.24706522057253e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23443.Degree of Unsaturation,39747,-0.0977461562338296,0.0108301428516747,-0.118973236223112,-0.0765190762445472,2.08409347538053e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39747,0.0548477653970222,0.0105789371451445,0.034113048592539,0.0755824822015054,2.20247967059942e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39747,0.136705436291624,0.010353152654039,0.116413257089708,0.15699761549354,1.64120587689228e-39
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39747,0.13124796073388,0.0104138398050055,0.11083683471607,0.151659086751691,3.57541160436451e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39747,0.174720136909348,0.0101123221614015,0.154899985473001,0.194540288345695,4.97943945696493e-66
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,39747,0.161878644051108,0.00982584677782941,0.142619984366562,0.181137303735654,2.86491003167321e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23449.Linoleic Acid,39747,0.136064896802532,0.0103361086355513,0.115806123876851,0.156323669728212,2.77383818668921e-39
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,39747,-0.000825850176736305,0.0105174271116266,-0.0214400073155244,0.0197883069620518,0.937414182334917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39747,-0.0364148048789112,0.0106009624655358,-0.0571926913113614,-0.0156369184464611,0.000594609208673791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39747,-0.131121408384994,0.0103119474180765,-0.151332825324424,-0.110909991445564,8.73233294266897e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39747,-0.147181421030769,0.0105373041337866,-0.167834537132991,-0.126528304928548,5.75994947803243e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39747,0.151020190088956,0.01111288108041,0.129238943171352,0.172801437006559,9.91029247355369e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39747,0.0813730226847903,0.00967549210073332,0.062409058167353,0.100336987202228,4.59058523978437e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39747,-0.0503124141648086,0.0106269068937555,-0.0711411516765693,-0.0294836766530479,2.22370166984069e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39747,-0.0989805741448666,0.0103322428524842,-0.119231770135736,-0.0787293781539975,1.17834043206777e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39747,-0.157998720144418,0.010969685106101,-0.179499302952376,-0.13649813733646,1.29332499017329e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39747,-0.00401140673427111,0.0104742108267154,-0.0245408599546333,0.016518046486091,0.701742358106288
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23460.Alanine,39754,0.0653095047284504,0.0104637122604825,0.0448006286979046,0.0858183807589961,4.49061364815149e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23461.Glutamine,39721,-0.0824621392998209,0.010240928833316,-0.10253435981312,-0.0623899187865214,8.95949704189914e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23462.Glycine,39744,0.095084518669353,0.012396472086871,0.0707874333790858,0.11938160395962,1.85901072311601e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23463.Histidine,39743,0.0586792634199764,0.0103265323625902,0.0384392599892997,0.0789192668506531,1.36166546383374e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39747,0.0845075620877074,0.0115602670712708,0.0618494386280166,0.107165685547398,2.8506062522203e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23465.Isoleucine,39755,0.0611699215473002,0.011162799512498,0.0392908345028042,0.0830490085917962,4.35057430209637e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23466.Leucine,39755,0.0726227815451842,0.0114382725153182,0.0502037674151606,0.0950417956752078,2.24986790303074e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23467.Valine,39747,0.0881781670775978,0.0115042557596836,0.065629825788618,0.110726508366578,1.93932861372863e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23468.Phenylalanine,39750,0.0303738113430197,0.010592078299822,0.00961333787536857,0.0511342848106708,0.00414377563785102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23469.Tyrosine,39745,0.0535695357910065,0.0110044452214573,0.0320008231569501,0.0751382484250629,1.1428518772906e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23470.Glucose,39739,0.0024939757925702,0.0100835066405638,-0.0172696972229348,0.0222576488080752,0.804655705929628
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23471.Lactate,39741,0.154291208542518,0.0105456002809977,0.133621831991762,0.174960585093273,4.97413640261741e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23472.Pyruvate,39718,0.061492910181428,0.0101423133678644,0.0416139759804137,0.0813718443824423,1.3793794439821e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23473.Citrate,39755,0.0618460794968322,0.0104989300169469,0.0412681766636162,0.0824239823300482,3.9565959837938e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39530,0.0539482229311048,0.0117161939040942,0.0309844828790802,0.0769119629831293,4.1795085240085e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23475.Acetate,39745,-0.0981591913944371,0.00996078319706836,-0.117682326460691,-0.0786360563281831,8.11812573458322e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23476.Acetoacetate,39756,0.0269045594403132,0.0105968618277319,0.00613471025795862,0.0476744086226678,0.0111330674943343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23477.Acetone,39756,-0.0549932962252799,0.0104710339194318,-0.0755165227073662,-0.0344700697431936,1.53271410568468e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23478.Creatinine,39551,0.0607751394036594,0.0129503859163992,0.0353923830075169,0.0861578957998018,2.72595336464011e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23479.Albumin,39755,0.0940688240950545,0.0104114553939855,0.073662371522843,0.114475276667266,1.90751100564585e-19
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,39757,0.197606642356507,0.0107173485866104,0.176600639126751,0.218612645586263,8.3628146520117e-75
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39757,0.150072987677509,0.010947376162381,0.128616130399242,0.171529844955775,1.98935835978942e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39757,0.145672612524234,0.010873348690958,0.124360849089957,0.166984375958512,1.29242751865607e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39757,0.155651946085634,0.0112397745100326,0.13362198804597,0.177681904125298,2.96657780799179e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39757,0.160263816210367,0.0110473702925869,0.138610970436897,0.181916661983837,2.94411055462157e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39757,0.164039526317715,0.0110303863158595,0.142419969138631,0.1856590834968,1.50113094215303e-49
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39757,0.150613925479698,0.0109845050598039,0.129084295562483,0.172143555396914,1.91244919293037e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39757,0.134229275507304,0.0106718331696756,0.11331248249474,0.155146068519868,4.90320048672122e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39757,0.180895459577681,0.0113397605164377,0.158669528965463,0.203121390189899,1.159385740167e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39757,0.17841700689994,0.0112632175644654,0.156341100473588,0.200492913326292,6.61982012546444e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39757,0.175554874904333,0.0112613312571953,0.15348266564023,0.197627084168436,3.21290346556443e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39757,0.177376994495034,0.0111994140498161,0.155426142957394,0.199327846032674,6.89492740005134e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39757,0.173550598432906,0.011200825699179,0.151596980062515,0.195504216803297,1.36556719803171e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39757,0.174261553486704,0.0111724930016011,0.152363467203566,0.196159639769842,2.83362068695209e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39757,0.174604311759013,0.0112947257253057,0.152466649337414,0.196741974180613,2.34435914811771e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39757,0.180348186351192,0.0111668765743076,0.15846110826555,0.202235264436835,5.13081098029639e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39757,0.178646906290598,0.0111300319456198,0.156832043677183,0.200461768904013,2.46597282365263e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39757,0.182234222369631,0.0113580804890265,0.159972384611139,0.204496060128123,2.72884825879734e-57
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39757,0.178669086690937,0.0112292776918275,0.156659702414955,0.200678470966919,2.21211910990951e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39757,0.168680521398037,0.0111647558775876,0.146797599877965,0.190563442918109,4.56294493078236e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39757,0.18399683413649,0.0113216921931052,0.161806317438004,0.206187350834976,1.02401901471623e-58
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39757,0.170867218577759,0.0109637453775309,0.149378277637798,0.192356159517719,3.43832778991517e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39757,0.152787571382729,0.0105924537705264,0.132026361992497,0.173548780772961,9.58988927651868e-47
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39757,0.16552863898157,0.0105906294239946,0.144771005310541,0.1862862726526,1.72497720686448e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39757,0.150449594043013,0.0105769499878456,0.129718772066836,0.171180416019191,1.61742411562968e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39757,0.100103829851243,0.0104627779098806,0.0795967851478774,0.120610874554609,1.32398935005541e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39757,0.0679091807106376,0.0104611323853665,0.0474053612353193,0.0884130001859559,8.85505732648201e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39757,0.135050692161638,0.010543013481662,0.114386385737581,0.155714998585696,2.65588768588293e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39757,0.177804132633419,0.0108356298183489,0.156566298189455,0.199041967077382,8.2277261524677e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39757,0.168301653450485,0.0108981148217258,0.146941348399902,0.189661958501067,2.97733237550175e-53
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39757,0.172007060080163,0.0109075395858022,0.150628282491991,0.193385837668335,1.99635733456714e-55
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39757,0.153375501171426,0.0107369992033226,0.132330982732914,0.174420019609939,6.90792502701344e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39757,0.139287178423865,0.0108568307318965,0.118007790189348,0.160566566658382,2.06095035998013e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39757,0.14398971983725,0.0110419440856727,0.122347509429332,0.165631930245169,1.38196928277907e-38
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39757,0.128632393709939,0.010575802329495,0.107903821144129,0.149360966275749,8.01803527239102e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39757,0.171079570995607,0.0109972353655352,0.149524989679158,0.192634152312056,5.28960791773597e-54
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39757,0.121576125252973,0.0105250491573803,0.100947028904507,0.142205221601438,1.08883205266488e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39757,0.122720578545157,0.0105891858444746,0.101965774289986,0.143475382800327,7.01968845984632e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39757,0.119011342014956,0.0105463241705002,0.0983405466407754,0.139682137389136,2.25442510154203e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39757,0.0879328795644757,0.0107051614414341,0.0669507631392649,0.108914995989687,2.37401460227092e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39757,0.0783529833302584,0.0107912612278518,0.0572021113236689,0.0995038553368478,4.10470270350764e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39757,0.10737046339921,0.0105809513041678,0.086631798843041,0.128109127955379,4.32374090016966e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39757,0.153205231651318,0.0107184184120507,0.132197131563699,0.174213331738938,6.09514522551363e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,39757,0.0919315601089469,0.0104886117969998,0.0713738809868273,0.112489239231066,2.13986959187592e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23524.Total Lipids in IDL,39757,0.0934135036799536,0.0107293448923281,0.0723839876909906,0.114443019668917,3.57910447562005e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23525.Phospholipids in IDL,39757,0.0896939396685599,0.0107203009827363,0.0686821497423968,0.110705729594723,6.62859373206103e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23526.Cholesterol in IDL,39757,0.0795692993166155,0.0107923754009255,0.0584162435308015,0.100722355102429,1.79000314724185e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39757,0.0829820693067518,0.0108064484642513,0.0618014303168193,0.104162708296684,1.73814467858135e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,39757,0.0678266371632246,0.0107124660109173,0.0468302037818266,0.0888230705446226,2.52016517319183e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23529.Triglycerides in IDL,39757,0.146338127038747,0.0103774737131877,0.125998278560899,0.166677975516595,9.00120258504843e-45
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39757,0.106019337946787,0.0103625824208412,0.0857086764019378,0.126329999491635,1.84722284491379e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,39757,0.110136690843117,0.0104171439159872,0.0897190887677825,0.130554292918452,5.29703858725329e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,39757,0.103393170574976,0.0104552818493915,0.0829008181501687,0.123885522999784,5.76989071293319e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,39757,0.102596158857583,0.0104258719024672,0.0821614499287469,0.123030867786419,9.32062146418087e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39757,0.110587729999171,0.010399800791315,0.0902041204481936,0.130971339550149,2.77651719145948e-26
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39757,0.0785354509154493,0.0105369176939101,0.0578830922353855,0.099187809595513,9.77249556683071e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,39757,0.155440121879437,0.0102632912447451,0.135324071039736,0.175556172719137,2.63249692086514e-51
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39757,0.131777276950915,0.0104267481208608,0.111340850634028,0.152213703267802,2.30097211191727e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39757,0.138000469478418,0.010361335234723,0.117692252418361,0.158308686538475,3.6449670664978e-40
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39757,0.132982241989952,0.0104089208257872,0.112580757171409,0.153383726808495,4.07241545935951e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39757,0.131903979327676,0.0103505317787436,0.111616937041339,0.152191021614014,6.11311490496334e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39757,0.143847091410434,0.0103718737894758,0.123518218783062,0.164175964037807,2.23605882918065e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39757,0.0912880061935033,0.0103440359478456,0.0710136957357259,0.111562316651281,1.25546423742975e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39757,0.167736169500199,0.0103103667907465,0.147527850590335,0.187944488410062,7.81116525650153e-59
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39757,0.133751813194922,0.0104355206603287,0.113298192700678,0.154205433689166,2.41516328429572e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,39757,0.128180281403251,0.0103033837061852,0.107985649339128,0.148374913467374,2.69602084933429e-35
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,39757,0.103104335367414,0.010301175588824,0.0829140312133194,0.123294639521509,1.7480792973584e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,39757,0.124649877958562,0.0103327047537839,0.104397776641145,0.144901979275978,2.64847327996848e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39757,0.141025113094877,0.0103202864822386,0.12079735158969,0.161252874600065,3.59532864322099e-42
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39757,0.0696096743699919,0.0103688510834069,0.0492867262465143,0.0899326224934694,1.99443636639408e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,39757,0.171282858325631,0.0104164991362926,0.150866520018497,0.191699196632764,4.74383533102255e-60
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39757,-0.0327465120696752,0.0120076256201042,-0.0562814582850793,-0.00921156585427099,0.00639852113828877
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39757,-0.067223782923039,0.0120278717115435,-0.0907984114776642,-0.0436491543684137,2.33741235253917e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39757,-0.0751666550815092,0.0119530870490683,-0.0985947056976832,-0.0517386044653353,3.32593218252203e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39757,-0.0768788640680383,0.0121874429448245,-0.100766252239894,-0.0529914758961823,2.93290817044674e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39757,-0.0793568193740517,0.0122590875742404,-0.103384631019563,-0.0553290077285404,9.99049439750603e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39757,-0.0640265325599603,0.0118288515048475,-0.0872110815094614,-0.0408419836104592,6.33516603546323e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39757,0.127234232779289,0.00997869774439071,0.107675985200283,0.146792480358294,5.60295773614835e-37
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39757,-0.0624538714078213,0.0121480150585415,-0.0862639809225627,-0.0386437618930799,2.77795720747589e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,39757,-0.0619998985636991,0.0120403011383605,-0.0855988887948856,-0.0384009083325126,2.65825137235852e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,39757,-0.0512763614448994,0.0119203568946101,-0.0746402609583352,-0.0279124619314636,1.71028593259042e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,39757,-0.0892542360054255,0.0122200477897762,-0.113205529673387,-0.0653029423374641,2.98554952574766e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39757,-0.0978911995747985,0.0122592766332156,-0.121919381775901,-0.0738630173736958,1.54218249266644e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39757,-0.0593790793039806,0.0120763715764556,-0.0830487675938336,-0.0357093910141275,8.91489321094796e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,39757,0.103072942749738,0.010535290727268,0.0824237729242925,0.123722112575183,1.63113008486912e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39757,0.0301187045617166,0.0111642062857299,0.00823686024168596,0.0520005488817472,0.00699060278935461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39757,0.0384476658700889,0.0109726866449448,0.0169412000459971,0.0599541316941807,0.000460220696124115
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39757,0.0500161856231943,0.010777842384242,0.0288916145500799,0.0711407566963086,3.51272646634326e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39757,0.00277656627138236,0.0112957177884521,-0.0193630405939837,0.0249161731367485,0.805836175380097
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39757,-0.0050383987528445,0.0112737797361903,-0.0271350070357775,0.0170582095300885,0.654946550238713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39757,0.034207786755107,0.0113562100597507,0.0119496150379956,0.0564659584722184,0.0025989693289148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39757,0.150796040044125,0.0107822427975821,0.129662844160864,0.171929235927386,4.49309149897995e-44
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39757,0.102218463075336,0.0103991414991076,0.0818361457370853,0.122600780413587,1.03897663677713e-22
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,39757,0.120224255610005,0.0103885526093778,0.0998626924956241,0.140585818724385,8.48770488873662e-31
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,39757,0.116209578718008,0.0103418764602251,0.095939500855967,0.13647965658005,3.85577563968907e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,39757,0.0866251309987292,0.0103576016753386,0.0663242317150656,0.106926030282393,6.81565542383027e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39757,0.0700386303647884,0.0104082564971674,0.0496384476303403,0.0904388130992366,1.79027809585152e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39757,0.123906085597088,0.0103238128408703,0.103671412428982,0.144140758765193,5.53649335228942e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,39757,0.184493788908485,0.0115589536456273,0.161838239763056,0.207149338053915,1.01015830159522e-56
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,0.00304298059676521,0.0117371640928085,-0.0199618610251395,0.0260478222186699,0.795439343120653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,-0.0371225287635508,0.0112740321795826,-0.0592196318355326,-0.015025425691569,0.000995319241612567
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,-0.0115851091041231,0.0114193592807805,-0.0339670532944528,0.0107968350862066,0.3103598367914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,-0.0755525711015779,0.0112093019666214,-0.0975228029561558,-0.053582339247,1.66248568375313e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,0.0295555827723639,0.0114194847403262,0.00717339268132459,0.0519377728634031,0.00966158987261164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39696,0.0390101570775123,0.0114559463641323,0.016556502203813,0.0614638119512116,0.000663420324735367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39696,-0.0932079429546725,0.0115893422109788,-0.115923053688191,-0.0704928322211539,9.69243663503458e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39696,-0.0923225733107965,0.0115293180399428,-0.114920036669084,-0.0697251099525087,1.28607279358121e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39696,-0.0718627881953852,0.0116040649757127,-0.0946067555477821,-0.0491188208429883,6.11579693217766e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39696,0.0705785804524013,0.0115698402498194,0.0479016935627552,0.0932554673420474,1.09452347915289e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39757,0.113778593284096,0.0119782874045151,0.0903011499712466,0.137256036596946,2.55740137746034e-21
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39757,-0.0460144443385885,0.0112042329440951,-0.0679747409090149,-0.0240541477681621,4.03899646080417e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39757,-0.0654718315268685,0.0113758229671713,-0.0877684445425242,-0.0431752185112128,8.87405927002271e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39757,0.0131694179543304,0.0113869013290238,-0.00914890865055628,0.035487744559217,0.247484712601659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39757,-0.00659748797555531,0.0114466931527678,-0.0290330065549801,0.0158380306038695,0.564379256705893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39757,-0.0163081402098004,0.011036907288248,-0.0379404784947664,0.00532419807516558,0.139542955527398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39757,-0.0702828155855201,0.011404559361548,-0.0926357519341542,-0.047929879236886,7.39854460713024e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39757,-0.0785191946407608,0.0114651044484011,-0.100990799359627,-0.0560475899218946,7.85310116870732e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39757,-0.0461035118098046,0.011170030205701,-0.0679967710129785,-0.0242102526066306,3.69507990096092e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39757,0.0585299933485476,0.0113126811525093,0.0363571382896293,0.0807028484074659,2.3331353655969e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39757,-0.0477776656842113,0.0111527745535611,-0.0696371038091911,-0.0259182275592315,1.8516236463984e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39757,-0.0447163463278252,0.010770377463502,-0.065826286156289,-0.0236064064993613,3.32337559193817e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39757,-0.0387410244262777,0.0105964082433963,-0.0595099845833344,-0.0179720642692209,0.000257306068469573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39757,-0.0508317224122424,0.0112488336421359,-0.0728794363508288,-0.0287840084736559,6.28176005934431e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39757,0.0462958618392624,0.0108792480188354,0.024972535722345,0.0676191879561797,2.10353438707956e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39757,-0.00840152425790179,0.0105523143397836,-0.0290840603638777,0.0122810118480741,0.425945317211546
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39757,-0.0608541666488689,0.0111043794947729,-0.0826187504586238,-0.039089582839114,4.3409060671625e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39757,-0.0610463856345074,0.0112480812524589,-0.0830926248893269,-0.039000146379688,5.84194864718168e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39757,-0.0430015290415057,0.00983521351368707,-0.0622785475283323,-0.023724510554679,1.24114665539921e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39757,0.0682128768485532,0.0109584613481146,0.0467342926062486,0.0896914610908578,4.9987762962862e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39757,-0.0508017509510143,0.0103242044030142,-0.0710371915809221,-0.0305663103211065,8.74914834937276e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39757,-0.0275556218360362,0.010808888148584,-0.0487410426072608,-0.00637020106481159,0.0108057036945436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39757,-0.0040248187558179,0.0106892638476978,-0.0249757758973055,0.0169261383856697,0.706530755711523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39757,-0.061063090561599,0.00992297576886127,-0.0805121230685671,-0.0416140580546309,7.82892867048029e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39757,0.0513635256645557,0.0108707514057735,0.0300568529092397,0.0726701984198718,2.3300678936458e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39757,-0.0815716014502394,0.0105032439556408,-0.102157959603295,-0.0609852432971834,8.78678119383546e-15
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39757,-0.00760883624486058,0.0107488255894317,-0.0286765344001467,0.0134588619104256,0.479037018256726
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39757,0.0714976405978911,0.0101996394708483,0.0515063472350285,0.0914889339607537,2.52399406738215e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39757,-0.0986024037233995,0.0114864463394861,-0.121115838548792,-0.0760889688980068,1.03553679160959e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39757,0.0413180995086415,0.010572421748439,0.0205961528817011,0.062040046135582,9.35738408332833e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39757,-0.0938593372569455,0.0107671864406509,-0.114963022680621,-0.0727556518332697,3.25564599595133e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39757,0.0113122399408546,0.0106807029300476,-0.00962193780203871,0.0322464176837479,0.289564060011904
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39757,0.127570704731864,0.0107259884933416,0.106547767284914,0.148593642178814,2.00557128193343e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39757,-0.127297598041701,0.0110530402175752,-0.148961556868148,-0.105633639215254,1.61153680193393e-30
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39757,0.0386649822438895,0.0105426908309411,0.018001308215245,0.0593286562725341,0.000246103162683755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39757,-0.152684929300706,0.0106853202442369,-0.17362815697941,-0.131741701622001,6.48699458194008e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39757,0.0442186265213139,0.0104715673043032,0.0236943546048797,0.0647428984377481,2.43272671393607e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39757,0.147204273533963,0.0105920185230829,0.126443917228721,0.167964629839206,1.5083292771043e-43
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39757,-0.10453600939224,0.0105319443735763,-0.125178620364449,-0.0838933984200301,4.01615470856354e-23
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39757,0.0936018949691461,0.0107471440779327,0.072537492576398,0.114666297361894,3.48290471620653e-18
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39746,-0.0922499522594837,0.0113796873606087,-0.114554139486277,-0.0699457650326906,5.75222324228641e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39746,0.000485585210922233,0.00992217286985031,-0.0189618736139844,0.0199330440358288,0.960968464746885
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39746,-0.0223410360443509,0.00926173624922864,-0.040494039092839,-0.00418803299586275,0.0158732125575953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39746,0.0523233387559696,0.011837167095148,0.0291224912494796,0.0755241862624597,9.95151985687736e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39746,0.163372436729133,0.0111240139119383,0.141569369461734,0.185175503996532,2.2265376907122e-48
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39757,0.0769407192908333,0.0105868769902298,0.0561904403899829,0.0976909981916838,3.9049892959785e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39757,-0.126077198839926,0.011146806701656,-0.147924939975172,-0.10422945770468,1.68273824670822e-29
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39757,-0.129537084787692,0.0107241674203737,-0.150556452931625,-0.10851771664376,2.20271724098537e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39757,-0.0153366641657172,0.0106646764013435,-0.0362394299123504,0.00556610158091612,0.150439235952439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39757,0.135649417176905,0.0107036238643905,0.114670314402699,0.15662851995111,1.48587880929174e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39757,0.0863110268883418,0.0114598615784318,0.0638496981946155,0.108772355582068,5.39945978443163e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39757,-0.12394971409765,0.0113843001321684,-0.1462629423567,-0.1016364858386,1.81157596924195e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39757,-0.133748934306001,0.0107903685323509,-0.154898056629409,-0.112599811982593,4.71736663552436e-35
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39757,0.0147330178184384,0.0119962458322877,-0.00877962401284551,0.0382456596497223,0.219421937451543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39757,0.139433392182996,0.0111869139654308,0.117507040810752,0.161359743555241,2.01960146385452e-35
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39757,-0.00324007656701614,0.0104187768125593,-0.0236608791196324,0.0171807259856002,0.755818326455934
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39757,-0.0750034035975834,0.0103272589083373,-0.0952448310579245,-0.0547619761372423,4.04822932442109e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39757,-0.0824097454990724,0.0101583152704475,-0.10232004342915,-0.0624994475689952,5.47636213216851e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39757,0.0394836112126045,0.0110852840972031,0.0177564543820863,0.0612107680431226,0.000369849856287188
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39757,0.140673937203503,0.0116293744704501,0.117880363241421,0.163467511165585,1.78630452874864e-33
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48486,0.0164445310915858,0.00874664596936774,-0.000698895008374997,0.0335879571915465,0.0601096476436219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48486,0.0119898008871871,0.00852354619484502,-0.00471634965470909,0.0286959514290834,0.159541443785821
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47094,0.0116981621478329,0.00818864839848608,-0.00435158871319985,0.0277479130088656,0.153141072561214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47094,0.00881719889035479,0.00891645889712992,-0.00865906054801985,0.0262934583287294,0.322740774936733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47094,0.0128344415905383,0.00879469255018421,-0.00440315580782271,0.0300720389888994,0.14448869295625
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47094,0.00541493239335438,0.00812190791126874,-0.0105040071127323,0.0213338718994411,0.504967660333681
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,48486,-0.0564588120967768,0.0267847059540507,-0.108956835766716,-0.00396078842683738,0.0350542841396339
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24010.Inverse distance to the nearest road,48486,-0.00788053358393585,0.00766981554494073,-0.0229133720520197,0.00715230488414797,0.304209971189178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,48486,0.015692001142174,0.00761607619047535,0.000764491808842319,0.0306195104755057,0.0393753303527349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,48486,0.00569459971649056,0.00777823847973818,-0.00955074770379627,0.0209399471367774,0.464104288210276
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24013.Total traffic load on major roads,48486,-0.0157124033490574,0.0186537804976875,-0.0522738131245248,0.02084900642641,0.399620460665388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,48486,-0.0110974672320678,0.0181963248716451,-0.0467622639804921,0.0245673295163566,0.541952180284712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48486,0.0253374297641242,0.00879770158938713,0.00809393464892542,0.042580924879323,0.00398092691515528
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48486,0.021783097222805,0.00879688707887667,0.00454119854820668,0.0390249958974032,0.0132861373763624
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48486,0.0252755799393263,0.00868909775840823,0.00824494833284617,0.0423062115458064,0.00363122627470241
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48447,0.0395252951851297,0.00846873220483791,0.0229265800636474,0.0561240103066121,3.07321848073093e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,48486,-0.00466362950866203,0.00763392592905704,-0.0196261243296138,0.0102988653122898,0.541267202922295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,48486,-0.00464533273278893,0.00763512426793033,-0.0196101762979324,0.0103195108323545,0.542918467426422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,48486,-0.00466605941586133,0.0076339505655882,-0.0196286025244142,0.0102964836926915,0.541057796505668
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48486,-0.00474715609514616,0.00763487846040275,-0.0197115178775355,0.0102172056872432,0.534098717510963
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48486,-0.00474357287847306,0.00763514969265373,-0.0197084662760744,0.0102213205191283,0.53442192205301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2405.Number of children fathered,48471,0.00217781904626571,0.0139718244691852,-0.0252069569133374,0.0295625950058688,0.876135340456562
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46211,-0.0199085341290722,0.00913891409604705,-0.0378208057573244,-0.00199626250082,0.0293868518807407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46211,0.0154515969655061,0.00821307830668861,-0.000646036515603566,0.0315492304466158,0.0599420944431644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",46211,-0.0169942502867506,0.00828429547503047,-0.0332314694178103,-0.000757031155690899,0.0402445702565788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46211,-0.0185241984847827,0.00856783222537238,-0.0353171496465126,-0.00173124732305287,0.0306266948071465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46211,0.0127885033716894,0.00830217213897379,-0.00348375402069927,0.029060760764078,0.123485618891572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",46211,-0.021428956333424,0.00832121423090404,-0.0377385362259959,-0.00511937644085211,0.0100257203515511
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48551,-0.0248308541646086,0.00865643058274127,-0.0417974581067815,-0.00786425022243567,0.00412873393052905
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48551,-0.0195867619911025,0.00811994574397399,-0.0355018556492916,-0.00367166833291352,0.0158664628025441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,48551,0.0504870266686371,0.00767053581675412,0.035452776467799,0.0655212768694752,4.75884998296544e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,34495,-0.00872525397443195,0.0140194889976763,-0.0362034524098776,0.0187529444610137,0.533725271176763
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35613,0.0110512534442708,0.0276855510375125,-0.0432124265892537,0.0653149334777953,0.689779784241238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35614,0.0216295359216274,0.0316042608627764,-0.0403148153694143,0.0835738872126691,0.493753627995712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35614,0.00205273870211951,0.0295411079799359,-0.0558478329385549,0.0599533103427939,0.944603537694027
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35605,-0.000501083711334494,0.0295562333364775,-0.0584313010508305,0.0574291336281615,0.986474138081309
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28739.Difficulty with standing for long periods,35617,-0.0152177514643831,0.0252948866451832,-0.0647957292889422,0.0343602263601759,0.54745072188155
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35633,-0.0472359812055848,0.02952662616359,-0.105108168486221,0.0106362060750515,0.109693271399301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28741.Difficulty learning a new task,35596,0.0254509294489368,0.0345242660031348,-0.0422166319172073,0.093118490815081,0.46103179647673
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28742.Difficulty with joining in community activities,35232,-0.0402870253345844,0.0316891776687736,-0.102397813565381,0.0218237628962118,0.203660108609698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35592,-0.0175005472187934,0.0279319522140751,-0.0722471735583806,0.0372460791207939,0.530979819653526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35641,-0.0198194183239677,0.0375421527094386,-0.0934020376344673,0.0537632009865319,0.597568454289454
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,33989,0.0154854522479193,0.0263946144263611,-0.0362479920277484,0.0672188965235871,0.557436608496009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2897.Age stopped smoking,34484,-0.000282299557992363,0.0147963089210285,-0.0292830650432082,0.0287184659272235,0.984778688790907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34797,0.000354518926345324,0.0311881635603148,-0.0607742816518718,0.0614833195045624,0.990930928844637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34797,-0.0410000635823868,0.0350199556754111,-0.109639176706193,0.0276390495414189,0.241739126515443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34797,0.379851256143808,0.117738241475356,0.149084302852112,0.610618209435505,0.00126082005730386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34797,0.0361486001798063,0.121244541237878,-0.201490700646434,0.273787901006047,0.765601571046019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34797,0.235182765832667,0.141809673043631,-0.0427641933328493,0.513129724998184,0.0972793945713966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34797,0.199847219867752,0.132479643796343,-0.0598128819730805,0.459507321708585,0.131474347067112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34797,-0.00873802676226586,0.0532196817327557,-0.113048602958467,0.0955725494339353,0.869588595963129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34797,-0.0292417997043162,0.102603511273673,-0.230344681800716,0.171861082392084,0.775655166613123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34770,0.0261425651211728,0.0300112077404779,-0.032679402050164,0.0849645322925095,0.38373705745884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29003.Recent feelings of depression,34771,0.0240074867205622,0.0296502148852546,-0.0341069344545369,0.0821219078956612,0.418149514149835
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34773,0.013422981978432,0.0233798805209683,-0.0324015838426658,0.0592475477995299,0.565903908570881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,34775,-0.0100989515503187,0.0229577154945517,-0.05509607391964,0.0348981708190026,0.660029589498956
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29006.Recent poor appetite or overeating,34781,-0.0160418047667204,0.0363686191959108,-0.0873242983907055,0.0552406888572647,0.659163861956982
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29007.Recent feelings of inadequacy,34763,0.00170077661935081,0.0323838226367408,-0.0617715157486612,0.0651730689873628,0.958116597359631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29008.Recent trouble concentrating on things,34779,0.00134896336826749,0.0313065824760644,-0.0600119382848187,0.0627098650213537,0.965632132454129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34774,0.041474643809323,0.0531178425736838,-0.0626363276350973,0.145585615253743,0.434947506576187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34758,-0.0858059504529263,0.0576323566563273,-0.198765369499328,0.0271534685934752,0.136578023032394
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,34869,0.0177172615288705,0.0584254750192753,-0.0967966695089091,0.13223119256665,0.761712850071358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),34869,-0.122803008168426,0.105806722657559,-0.330184184577242,0.0845781682403904,0.245834473606458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),34869,-0.0503999958085061,0.0667558213381958,-0.18124140563137,0.0804414140143576,0.450283180197138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),34869,0.201856931776872,0.197259311562517,-0.184771318885661,0.588485182439404,0.306201966807609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),34869,-0.187156375845435,0.1317016593013,-0.445291628075983,0.0709788763851132,0.155348137674566
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),34869,0.087471016937621,0.154686906372198,-0.215715319551887,0.390657353427128,0.571773428812004
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),34869,-0.0778017788265597,0.158016697063727,-0.387514505071465,0.231910947418346,0.622479081084647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),34869,-0.147679442983297,0.185363096320189,-0.510991111770868,0.215632225804274,0.42565337294694
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),34869,-0.00657387496465201,0.129494905142095,-0.260383889043158,0.247236139113854,0.959513991405221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,34869,-0.048563873382097,0.055579141064964,-0.157498989869426,0.0603712431052324,0.382272215095929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,34869,-0.204743030657267,0.0893358457342061,-0.379841288296311,-0.0296447730182226,0.0219481531392738
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,34869,-0.046878074731905,0.146013508017478,-0.333064550446162,0.239308400982352,0.748180929351362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,34869,0.187446729489251,0.173295915652695,-0.152213265190032,0.527106724168534,0.279446599752558
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,34869,0.0150251982016993,0.110535337654046,-0.20162406360023,0.231674460003629,0.89188005547459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,34869,-0.172101961930599,0.163235252857975,-0.492043057532231,0.147839133671032,0.291777711418844
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,34869,0.0410685881430926,0.158123743930936,-0.268853949961543,0.350991126247728,0.795084929779142
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,34869,-0.0504655924975888,0.0888388824660678,-0.224589802131082,0.123658617135904,0.57001627696589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,34869,0.103714404263639,0.0882819902112129,-0.0693182965503378,0.276747105077617,0.240116087563772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,34869,0.00198875518586956,0.132549153635494,-0.257807585939698,0.261785096311437,0.98802954077601
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34678,-0.0157423846178666,0.0288684644086844,-0.072324574858888,0.0408398056231549,0.585557431080856
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29059.Recent inability to stop or control worrying,34682,0.019932440668514,0.0305551346406325,-0.0399556232271258,0.0798205045641537,0.514204324407816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29060.Recent worrying too much about different things,34682,0.00566275005730029,0.0274244574964268,-0.0480891866356963,0.0594146867502969,0.836418682687787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29061.Recent trouble relaxing,34678,0.00810603856762398,0.0291601481598028,-0.0490478518255896,0.0652599289608375,0.781034522185898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29062.Recent restlessness,34686,0.0885731154169037,0.0401877900504266,0.00980504691806761,0.16734118391574,0.0275630139452657
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29063.Recent easy annoyance or irritability,34676,-0.0120511477191696,0.0279713171093455,-0.0668749292534869,0.0427726338151476,0.666600378812169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29064.Recent feelings of foreboding,34680,0.00813241656212249,0.0348826777979448,-0.0602376319218493,0.0765024650460943,0.815663460405046
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,34869,-0.103199530173756,0.0693504530356704,-0.23912641812367,0.0327273577761582,0.136778162889659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,34869,-0.272930759519078,0.104806494562299,-0.478351488861184,-0.0675100301769718,0.0092322476026893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',34869,-0.273265678491033,0.146117078632641,-0.559655152611009,0.0131237956289441,0.0615049736655301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,34869,-0.0417967946210169,0.14233081571516,-0.32076519342273,0.237171604180696,0.769027834180149
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,34869,-0.0761838853582216,0.0907830666326068,-0.254118695958131,0.101750925241688,0.401396898867882
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,34869,-0.192311864964929,0.112819246408374,-0.413437587925342,0.0288138579954835,0.0883183072778621
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,34869,-0.0103862005367617,0.106898417837778,-0.219907099498807,0.199134698425284,0.922602808503775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,34869,-0.226473693290462,0.11119679141019,-0.444419404454434,-0.00852798212649047,0.0417227782902098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,34869,-0.00910656815658967,0.133575325392712,-0.270914205926306,0.252701069613126,0.945648082768797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29076.Felt loved as a child,34654,0.00856488448760976,0.0232409264687886,-0.0369873313912159,0.0541171003664354,0.712493992020322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29077.Physically abused by family as a child,34663,-0.0246628910861376,0.0299464547308391,-0.0833579423585821,0.034032160186307,0.410218436945478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29078.Felt hated by family member as a child,34656,-0.0087342464014008,0.0341158570641437,-0.0756013262471224,0.0581328334443208,0.797946251379024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29079.Sexually molested as a child,34642,0.122753552437127,0.0506071885120397,0.0235634629535292,0.221943641920725,0.0153115888414658
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,34651,-0.0453311624142764,0.0355878496991309,-0.115083347824573,0.0244210229960202,0.202789633862066
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34660,0.0286411004160844,0.0517897763195125,-0.07286686117016,0.130149062002329,0.580265909349021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34645,0.0297767629473617,0.0442027240281277,-0.0568605761477686,0.116414102042492,0.500565400912146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34670,0.0677687130251974,0.049181422070418,-0.0286268742328219,0.164164300283217,0.168274723166172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34663,0.145033242686383,0.154122627545179,-0.157047107302167,0.447113592674933,0.346729553999478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34656,0.129209443231005,0.0926306633249224,-0.0523466568858433,0.310765543347852,0.163100642768323
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29086.Experienced a violent or sexual assault,34675,0.0182857601528159,0.0528223911710636,-0.0852461265424689,0.121817646848101,0.729223634356602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,34667,-0.0276958530889685,0.0266845247827545,-0.0799975216631674,0.0246058154852304,0.299358248100275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29088.Experienced a marital separation or divorce,34667,0.0159829142173438,0.0266681243462691,-0.0362866095013435,0.0682524379360312,0.548977547613912
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29089.Experienced the death of a spouse or partner,34678,-0.00522988405999607,0.040570471654814,-0.0847480085034314,0.0742882403834393,0.897434211078308
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34668,0.00544760049164236,0.0329779448196485,-0.0591891713548687,0.0700843723381535,0.86880056517894
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34664,-0.052400211633216,0.0214249373042672,-0.0943930887495796,-0.0104073345168524,0.0144830445019877
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34164,-0.0653032231396515,0.0229824893601548,-0.110348902285555,-0.0202575439937481,0.00450745665322444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34181,-0.0612225176803179,0.0228436071927441,-0.105995987778096,-0.0164490475825394,0.00738225478628195
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29104.Ever used cannabis,34660,-0.0529087277916069,0.0288312584377798,-0.109417994329655,0.00360053874644146,0.0665373878600837
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29108.Ever thought that life not worth living,34638,0.00958106895585512,0.0290002910208763,-0.0472595014450625,0.0664216393567727,0.741125545382992
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29109.Ever contemplated self-harm,34642,0.0473826552857344,0.040706591915827,-0.0324022648692865,0.127167575440755,0.244468166036814
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29111.Ever self-harmed,34654,0.115719180219346,0.0715409778252562,-0.0245011363181565,0.255939496756848,0.105817531328619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34656,-0.000948749489522302,0.0440983248311536,-0.0873814661585834,0.0854839671795388,0.982836016626593
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35330,-0.065862696108872,0.146805234668492,-0.353600956059117,0.221875563841373,0.653705839319412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35330,-0.224186540955753,0.113329666916258,-0.446312688111618,-0.00206039379988782,0.0479490615904752
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35330,-0.213597366997831,0.135358577739987,-0.478900179368205,0.0517054453725429,0.11461000923458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35330,-0.216869457461349,0.236679359154635,-0.680761001404434,0.247022086481736,0.359542043861273
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34643,-0.0307688835287283,0.0248290156381588,-0.0794337541795196,0.0178959871220629,0.21530813296039
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X29153.Pain or discomfort today,34656,0.028821899178303,0.0227937295099879,-0.0158538106612732,0.0734976090178792,0.206111450986813
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29154.Anxiety or depression today,34656,-0.00166012742691505,0.0303701950656153,-0.0611857097555211,0.057865454901691,0.956408712865785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29166.Frequency of confiding in someone close,34501,-0.00658345576639439,0.0227009690076017,-0.0510773550212936,0.0379104434885049,0.771820544974324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34642,0.00862122686802267,0.0293238471819351,-0.0488535136085701,0.0660959673446154,0.768767590606409
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34642,-0.0115327544871539,0.0303406573570413,-0.0710004429069549,0.0479349339326471,0.703877925782301
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34642,0.0356836415367068,0.0322023753724828,-0.0274330141933595,0.0988002972667732,0.26786019985633
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34642,0.00714402637441988,0.0444949157494422,-0.0800660084944869,0.0943540612433267,0.872446697385409
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34642,-0.00519774462908133,0.0886126395648415,-0.178878518176171,0.168483028918008,0.953227311798459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34642,0.015638328657884,0.0325914879816153,-0.048240987786082,0.0795176451018501,0.631366630056119
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34636,-0.00900142451784978,0.034114077555026,-0.0758650165257007,0.0578621674900012,0.791894908861599
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34636,-0.0134888696197814,0.0539878498947205,-0.119305055413434,0.0923273161738708,0.802711777429271
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34636,0.00255480829754846,0.0606708441604927,-0.116360046257017,0.121469662852114,0.966412939240811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34636,0.108888634776831,0.0753244873930265,-0.038747360513501,0.256524630067163,0.148342997693776
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34636,0.154708390261723,0.127411657189775,-0.0950184578302358,0.404435238353681,0.224703414774285
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34636,0.0560276644417087,0.0487214773139487,-0.0394664310936307,0.151521759977048,0.250206629395227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34487,0.0303737985956077,0.0277354511773734,-0.0239876857120442,0.0847352829032596,0.273506486981492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,34602,0.011938170095221,0.0261065876837024,-0.0392307417648357,0.0631070819552778,0.647482236298862
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29173.Frequency of feeling left out,34574,0.0436285914214865,0.0269174335586572,-0.00912957835348161,0.0963867611964545,0.105106827082816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29174.Frequency of feeling isolated from others,34604,0.0240811896930005,0.0275669555420139,-0.0299500431693467,0.0781124225553476,0.382396812681215
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34649,-0.0019760873842756,0.022245186754985,-0.0455766534240461,0.0416244786554949,0.929218262544706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29176.Ability to make it through stressful events,34649,-0.00406386917068084,0.0216528198179603,-0.046503396013883,0.0383756576725213,0.851131347430819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29177.Quick recovery from stressful events,34649,0.0117810473155267,0.0221533503887284,-0.0316395194463809,0.0552016140774343,0.594887326426791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29178.Hard to snap back when something bad happens,34649,0.0198857169946626,0.021823639470515,-0.0228886163675468,0.062660050356872,0.362225928068329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29179.Comes through difficult times with little trouble,34649,0.00219918405256486,0.0221550310886877,-0.041224676881263,0.0456230449863927,0.920932416124582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34649,-0.00538049891011861,0.021917274367207,-0.0483383566698444,0.0375773588496072,0.806084420791639
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29181.General happiness,34615,-0.00310039151477585,0.0225955032263272,-0.0473875778383771,0.0411867948088254,0.890867215397479
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,X29182.Belief that own life is meaningful,34535,-0.0149296412997832,0.0228833666445636,-0.0597810399231278,0.0299217573235614,0.514153425559487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,33923,0.0104646487877628,0.0236377969512694,-0.0358654332367252,0.0567947308122507,0.657994733758412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2946.Father's age,32819,-0.00223331517689672,0.0254303235395709,-0.0520767493144557,0.0476101189606622,0.930023154157397
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,34443,0.0368108424616058,0.0189281297617201,-0.000288291871365552,0.0739099767945771,0.0518506870322536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,48166,0.0833744687413849,0.0081667143012515,0.067367708710932,0.0993812287718378,2.07945929289196e-24
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48167,-0.000264241114625009,0.00887881606235896,-0.0176667205968486,0.0171382383675985,0.97625808547698
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30020.Haemoglobin concentration,48167,-0.048868119606518,0.00939444821588657,-0.0672812381096556,-0.0304550011033803,1.99347567859247e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30030.Haematocrit percentage,48167,-0.0325453880648425,0.00921324328458908,-0.0506033449026371,-0.0144874312270479,0.000412664696174734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30040.Mean corpuscular volume,48167,-0.0434914313275863,0.00810462893726619,-0.059376504044628,-0.0276063586105445,8.13067377707477e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48167,-0.0551323864005935,0.00811726903459093,-0.0710422337083917,-0.0392225390927953,1.13775666404552e-11
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48167,-0.033013916335551,0.00792543761854596,-0.0485477740679011,-0.0174800586032009,3.11915887229244e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48167,0.0305530015361138,0.00826369660410573,0.0143561561920666,0.046749846880161,0.000218537836072036
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30080.Platelet count,48167,0.349654808299076,0.00771891884733978,0.33452572735829,0.364783889239861,0
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30090.Platelet crit,48167,0.297442620539813,0.00798882446049966,0.281784524597234,0.313100716482392,3.24033857007312e-293
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48167,-0.182082484549461,0.00755676003741137,-0.196893734222787,-0.167271234876135,1.93899273242132e-126
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30110.Platelet distribution width,48167,-0.0861427647648372,0.0078816800698593,-0.101590857701761,-0.0706946718279129,1.00203975685853e-27
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30120.Lymphocyte count,48133,0.0677945842210868,0.00792666199127833,0.0522583267181813,0.0833308417239923,1.28951385828994e-17
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30130.Monocyte count,48133,0.035763877158013,0.00800423817896203,0.0200755703272474,0.0514521839887786,7.93540307790477e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30140.Neutrophill count,48133,0.0600246497225161,0.00808362307254767,0.0441807485003226,0.0758685509447095,1.16999577708212e-13
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30150.Eosinophill count,48133,0.0405415087674075,0.00767005402570057,0.0255082028770344,0.0555748146577806,1.26578872762287e-07
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30160.Basophill count,48133,0.0932263776565864,0.0136322172725877,0.0665072318023144,0.119945523510858,8.22888746794372e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,48133,-0.0756586641039814,0.0721691626801619,-0.217110222957099,0.0657928947491359,0.294489571675146
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30180.Lymphocyte percentage,48134,0.00597868145695016,0.00787891563882488,-0.0094639931951466,0.0214213561090469,0.4479691912503
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30190.Monocyte percentage,48134,-0.023346020591971,0.00790227545514411,-0.0388344804840535,-0.00785756069988858,0.00313710641094592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30200.Neutrophill percentage,48134,-0.00215364043409771,0.00776831164595419,-0.0173795312601679,0.0130722503919725,0.781603335822957
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30210.Eosinophill percentage,48134,0.0160788169724281,0.00761156517560633,0.0011601492282397,0.0309974847166165,0.0346631590061853
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30220.Basophill percentage,48134,-0.0185340880620011,0.00800209274940214,-0.0342181898508293,-0.00284998627317294,0.020560098949121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,48133,-0.0754400577863666,0.0722392039765404,-0.217028897580386,0.0661487820076525,0.296355330242984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30240.Reticulocyte percentage,47819,0.0278579954678659,0.00840557255104686,0.0113830732678141,0.0443329176679178,0.000920659940333369
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30250.Reticulocyte count,47819,0.0276372332480119,0.00849575720580202,0.0109855491246399,0.0442889173713838,0.00114365214021068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,47819,-0.0493563525275372,0.00797264002057916,-0.0649827269678724,-0.0337299780872021,6.11053450402867e-10
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30270.Mean sphered cell volume,47819,-0.0240170582662865,0.00801121917977951,-0.0397190478586543,-0.00831506867391861,0.00272169383093442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,47819,0.00144588837589448,0.00828145700750429,-0.0147857673588139,0.0176775441106029,0.861400913297798
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47819,0.0196875676868766,0.00851841336572599,0.00299147749005364,0.0363836578836995,0.0208335643321043
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,47819,0.0195591488414498,0.00856084915821257,0.00277988449135318,0.0363384131915465,0.0223400599151878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30500.Microalbumin in urine,35774,-0.0103971440738329,0.0124620574996125,-0.0348227767730735,0.0140284886254077,0.404137493486034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48204,-0.00403077669364755,0.0085870130508884,-0.0208613222733888,0.0127997688860937,0.638786241822323
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30520.Potassium in urine,48168,-0.0170503245135954,0.00800638665651293,-0.0327428423603608,-0.00135780666683007,0.0332178853033603
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30530.Sodium in urine,48173,-0.00591747933621337,0.00829203613910269,-0.0221698701688546,0.0103349114964279,0.475462005412061
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30600.Albumin,46321,0.064951570375709,0.00848562162375267,0.0483197519931538,0.0815833887582642,2.043103765109e-14
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30610.Alkaline phosphatase,47795,0.022223411733558,0.0083580108060108,0.0058417105537768,0.0386051129133391,0.00784529983129307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30620.Alanine aminotransferase,47780,0.008805234568948,0.00902231864745489,-0.00887850998006359,0.0264889791179596,0.329106896523019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30630.Apolipoprotein A,46268,-0.0338041417685394,0.00920053081635463,-0.0518371821685945,-0.0157711013684843,0.000239346482721259
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30640.Apolipoprotein B,47654,0.0968267079878877,0.00779985922071905,0.0815389839152783,0.112114432060497,3.00689343626443e-35
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,47727,-0.0036520501445737,0.00830618380821824,-0.0199321704086814,0.012628070119534,0.660174969619475
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30660.Direct bilirubin,46465,-0.0697722552483928,0.00845235157868485,-0.0863388643426151,-0.0532056461541705,1.62687171331419e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30670.Urea,47784,-0.0144023273805884,0.00826865935991694,-0.0306088997260256,0.00180424496484885,0.0815599715316834
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30680.Calcium,46312,0.0987676772543255,0.00839606502320561,0.0823113898088425,0.115223964699809,7.89975614022091e-32
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30690.Cholesterol,47798,0.0985272757741173,0.00786123970005487,0.0831192459620097,0.113935305586225,6.78324924011918e-36
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30700.Creatinine,47790,-0.0215436477596447,0.0104074912261337,-0.0419423305628668,-0.00114496495642258,0.0384644230004999
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30710.C-reactive protein,47725,0.0054430072093572,0.00872157101720542,-0.0116512719843654,0.0225372864030798,0.532578789446198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30720.Cystatin C,47804,0.00275706989432807,0.00955331168222444,-0.0159674210028318,0.021481560791488,0.772891880709911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,47787,0.0262168055710518,0.00949067685619238,0.00761507893291472,0.0448185322091888,0.00574371982535198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30740.Glucose,46292,0.0150053751918746,0.00803538123018664,-0.000743972019291203,0.0307547224030404,0.0618604616815047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47706,0.0171578694865265,0.00806022789261951,0.00135982281699229,0.0329559161560608,0.0332912037880199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30760.HDL cholesterol,46303,-0.0562866685775343,0.00948322874405859,-0.0748737969158891,-0.0376995402391795,2.98615784430349e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30770.IGF-1,47708,-0.0149341484488848,0.00839974858104007,-0.0313976556677233,0.00152935876995371,0.0754315749814038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30780.LDL direct,47755,0.0956366893092393,0.00784007399453463,0.0802701442799515,0.111003234338527,4.2399037822624e-34
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30790.Lipoprotein A,43943,-0.000137944196163795,0.00863004882470848,-0.0170528398925924,0.0167769515002648,0.987247225777099
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30810.Phosphate,46273,0.0443565574051663,0.008168838526381,0.0283456338934595,0.060367480916873,5.7106742258426e-08
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30830.SHBG,46192,-0.0748591066360098,0.0108766463710399,-0.0961773335232481,-0.0535408797487715,6.07711435199651e-12
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30840.Total bilirubin,47718,-0.0704043773724823,0.00858440489059932,-0.087229810958057,-0.0535789437869077,2.52431836001189e-16
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30850.Testosterone,47607,-0.0445544051453254,0.0134283688406024,-0.0708740080729061,-0.0182348022177447,0.000908570340647213
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30860.Total protein,46291,0.118467569716993,0.00831221935522991,0.102175619780742,0.134759519653243,7.78976084164645e-46
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30870.Triglycerides,47777,0.16737485284648,0.00813426590531966,0.151431691672053,0.183318014020907,4.50695677546393e-93
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30880.Urate,47771,0.00587019283939709,0.00994206785118382,-0.0136162601489232,0.0253566458277174,0.554902774740856
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Blood and urine assays,X30890.Vitamin D,47216,-0.0522542629926216,0.00885554841139529,-0.0696111378789564,-0.0348973881062869,3.68153489829178e-09
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3137.Number of measurements made,46675,0.00262495927670123,0.0163458818686719,-0.0294129691858957,0.0346628877392981,0.872419373917634
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3143.Ankle spacing width,39925,-0.00203720315306188,0.0144213614088515,-0.0303030715144108,0.026228665208287,0.887664779653581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39925,-0.00389331789532398,0.0104611137079999,-0.0243971007630038,0.0166104649723559,0.7097728740041
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3146.Speed of sound through heel,39925,-0.0132734798015483,0.0101570870600549,-0.0331813704392559,0.00663441083615937,0.191300543681425
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39925,-0.0105986088526816,0.0102406012820731,-0.0306701873655447,0.00947296966018163,0.300709866446964
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X3148.Heel bone mineral density (BMD),39906,-0.0106492344064494,0.0103176542067095,-0.0308718366516,0.00957336783870124,0.302029941407992
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X3526.Mother's age at death,40607,-0.012957149342736,0.0101706748217983,-0.0328916719934607,0.00697737330798867,0.202698193070529
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32304,-0.00523792929142423,0.0189966173982729,-0.042471299392039,0.0319954408091906,0.782771157499436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4100.Ankle spacing width (left),35143,-0.0345246232132837,0.019360576200872,-0.0724713525669928,0.00342210614042546,0.0745930028263278
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35141,0.00160298465524849,0.0140407030113696,-0.0259167932470358,0.0291227625575328,0.909108931111147
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4103.Speed of sound through heel (left),35143,0.00280263449976497,0.0134756980076565,-0.0236097335952418,0.0292150025947717,0.835253442209141
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35143,0.00203640610357993,0.0136549998941002,-0.0247273936888566,0.0288002058960164,0.881453571605816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35137,0.0014243312658824,0.0136824850442759,-0.0253933394208983,0.0282420019526631,0.917094079126959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35143,0.0020288921828684,0.0136560120688288,-0.0247368914720361,0.0287946758377729,0.881896457926181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4119.Ankle spacing width (right),35130,-0.024863163761242,0.0190288386023725,-0.0621596874218921,0.012433359899408,0.191393125137307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35129,0.00338764656877009,0.0141054330044268,-0.0242590021199064,0.0310342952574466,0.81020904738008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4122.Speed of sound through heel (right),35130,0.00926860402057936,0.0133972299345122,-0.0169899666510646,0.0355271746922233,0.489068764633417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35130,0.00790797625674409,0.0136372520323665,-0.0188210377266943,0.0346369902401824,0.56201522629995
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35122,0.0116458782752018,0.0136726431836025,-0.0151525023646592,0.0384442589150627,0.394375835743487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35130,0.00791205061789635,0.013637319940331,-0.0188170964651524,0.0346411977009451,0.561815713262922
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4194.Pulse rate,35472,0.0315650137461362,0.0126390647745679,0.00679244678798309,0.0563375807042894,0.0125333869188105
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4195.Pulse wave reflection index,35472,-0.00520822433379135,0.0132225679853582,-0.0311244575850934,0.0207080089175107,0.693675198947584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4196.Pulse wave peak to peak time,35464,-0.017346304742621,0.0146010044856334,-0.0459642735344624,0.0112716640492205,0.234866112276194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4198.Position of the pulse wave peak,35472,0.0143129499392683,0.0157487883768448,-0.0165546752793476,0.0451805751578841,0.363472457044914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4199.Position of pulse wave notch,35472,0.0144949070052844,0.0127446217186904,-0.0104845515633488,0.0394743655739175,0.255437835248316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,35472,0.00427967001588796,0.0160750705744269,-0.0272274683099887,0.0357868083417646,0.790069876524064
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4269.Number of triplets attempted (left),35270,0.0031066485967754,0.0662672239488041,-0.126777110342881,0.132990407536431,0.962609779941064
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4270.Volume level set by participant (left),35195,-0.0119597421098438,0.0207916905831895,-0.0527114556528951,0.0287919714332076,0.565163911668879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4276.Number of triplets attempted (right),35274,-0.0795467724262239,0.0651007571484076,-0.207144256437103,0.0480507115846549,0.221787771164576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X4277.Volume level set by participant (right),35199,0.00771517689095739,0.020562487086186,-0.0325872977979671,0.0480176515798819,0.707519029911644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4288.Time to answer,35441,0.0317541675991299,0.0151476972073547,0.00206468107271469,0.0614436541255452,0.0360919348618398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Cognitive function,X4290.Duration screen displayed,35441,-0.00957640725636586,0.0139541987732525,-0.0369266368519408,0.0177738223392091,0.492563443922101
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X46.Hand grip strength (left),48678,0.00664849381575697,0.0104950648998553,-0.0139218333879594,0.0272188210194734,0.526422470484329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X47.Hand grip strength (right),48674,0.00777937118496127,0.0103460244156029,-0.0124988366696204,0.0280575790395429,0.452108653831157
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X48.Waist circumference,48730,0.0410478125601084,0.0196010266931933,0.00262980024144951,0.0794658248787672,0.0362576283840544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X4803.Tinnitus,35306,-0.0595014914252585,0.023981526691211,-0.106505283740032,-0.0124976991104849,0.0131206839181627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4825.Noisy workplace,35378,0.0339119852146779,0.0225709727877532,-0.0103271214493185,0.0781510918786742,0.133024933854282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Working and living environment,X4836.Loud music exposure frequency,35337,0.0288265715497998,0.0303417503048841,-0.0306432590477731,0.0882964021473727,0.34211437874776
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X49.Hip circumference,48723,-0.0250542459768342,0.0144034982756982,-0.0532851025972027,0.00317661064353435,0.081969943070565
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X50.Standing height,48689,-0.0339704970502508,0.0109018137260356,-0.0553380519532806,-0.0126029421472211,0.00183555118839334
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X5057.Number of older siblings,34577,0.0163804987712729,0.0219816267956551,-0.0267034897482111,0.0594644872907569,0.456185889996112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,X51.Seated height,48604,-0.0229077789161381,0.00952007090695949,-0.0415671178937787,-0.00424843993849749,0.0161257390729782
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5181.Ever had eye surgery,33237,-0.00330323905946369,0.0516494755884311,-0.104536211212789,0.0979297330938613,0.949008864689933
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33227,0.0136351164241284,0.0160865593273484,-0.0178945398574745,0.0451647727057313,0.396699464558937
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33224,0.0462713248232209,0.016526885640936,0.0138786289669864,0.0786640206794554,0.00513526600772784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),33179,0.0401323263197233,0.0165513938060505,0.00769159445986432,0.0725730581795822,0.015359074666984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),33176,0.0370194139441985,0.0166998552502064,0.00428769765379404,0.069751130234603,0.0266891221177996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5199.logMAR, initial (right)",33206,0.0493589868337987,0.0260527059364447,-0.0017043168016328,0.10042229046923,0.0582103965770495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5200.Final number of letters displayed (right),33206,0.0941750162796239,0.165598099279041,-0.230397258307296,0.418747290866544,0.569590038577678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5201.logMAR, final (right)",33153,0.0173210905260808,0.0159965619550466,-0.0140321709058105,0.0486743519579721,0.278954178564731
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5202.Number of rounds to result (right),33206,0.0456476106684917,0.0246594137427624,-0.0026848402673226,0.093980061604306,0.0642159698800546
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5206.logMAR, initial (left)",33202,0.0103056493870117,0.026029821793942,-0.0407128013291147,0.0613241001031381,0.692184605020712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5207.Final number of letters displayed (left),33202,0.231071622107295,0.172959298844213,-0.107928603627362,0.570071847841952,0.181619143625484
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5208.logMAR, final (left)",33165,-0.00183760394501598,0.0162272645404239,-0.0336430424442468,0.0299678345542148,0.909843870875321
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5209.Number of rounds to result (left),33198,0.046868333864508,0.0248239045550688,-0.00178651906342677,0.0955231867924429,0.0590846702248523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33033,-0.000764873498024004,0.015972815395751,-0.032071591673696,0.030541844677648,0.961809291019461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33033,0.000608528389672665,0.015702969873833,-0.0301692925630401,0.0313863493423854,0.969089509120327
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5256.Corneal hysteresis (right),33033,0.00148160737199546,0.0162963006224296,-0.0304591418479666,0.0334223565919575,0.927562815123869
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5257.Corneal resistance factor (right),33033,0.00305550085163121,0.0160671669521498,-0.0284361463745824,0.0345471480778449,0.849184249928292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33010,0.0263477072147616,0.0160870646531089,-0.00518293950533174,0.057878353934855,0.101530707516119
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33010,0.0208005403388226,0.015939736132295,-0.0104413424804757,0.0520424231581208,0.191978351774223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5264.Corneal hysteresis (left),33010,-0.0148168452918343,0.0161241492926429,-0.0464201779054143,0.0167864873217457,0.35818631134655
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X5265.Corneal resistance factor (left),33010,0.00101658970727948,0.0160393942946595,-0.0304206231102531,0.032453802524812,0.949466145114088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33781,0.041377306997331,0.120132527772664,-0.194082447437091,0.276837061431753,0.730536534263176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48682,-0.0487455633310053,0.0427956262243731,-0.132624990730777,0.0351338640687661,0.254703631994818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48682,-0.0292676465241339,0.0489357166417192,-0.125181651141904,0.0666463580936357,0.549790938857691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48682,-0.0264609498844635,0.123069621598754,-0.267677408218021,0.214755508449094,0.829763285632116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48682,-0.0369148364111541,0.0193998762862769,-0.0749385939322569,0.00110892110994865,0.0570758760877107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48682,0.0330947445532979,0.0180018761754619,-0.00218893275060734,0.0683784218572032,0.0660174641658015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37418,-0.0175668874511743,0.0231704174908913,-0.0629809057333212,0.0278471308309725,0.448375369269959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37418,-0.0820204729605349,0.0705173358851403,-0.22023445129541,0.0561935053743401,0.244810283325538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37418,-0.0197095922718585,0.044669271913449,-0.107261365222218,0.0678421806785015,0.659054569247077
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37418,0.0363230370119927,0.0269575341230194,-0.0165137298691252,0.0891598038931107,0.177880620844885
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48744,-0.0657337935371103,0.0407375897935887,-0.145579469532544,0.0141118824583235,0.106631912233527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48744,-0.0657337935371103,0.0407375897935887,-0.145579469532544,0.0141118824583235,0.106631912233527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48744,0.0370913934664382,0.0297701082241241,-0.0212580186528451,0.0954408055857215,0.21280554081158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48744,-0.0716798687882972,0.052433749314696,-0.174450017445101,0.0310902798685069,0.171623025018448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48744,0.160826091345412,0.123115409638189,-0.0804801115454384,0.402132294236262,0.19146428005343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48744,0.0695058230952351,0.0867317529904915,-0.100488412766128,0.239500058956598,0.42291626543231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48744,0.321796912290832,0.13302042127601,0.0610768865898527,0.582516937991812,0.015565443199521
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48681,-0.00195933637990416,0.0265914754836044,-0.0540786283277688,0.0501599555679605,0.941263458932023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48681,0.0875144112940931,0.0463947654999039,-0.00341932908571851,0.178448151673905,0.0592690569990957
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48681,0.0186552878369911,0.0241617265480588,-0.0287016961972041,0.0660122718711863,0.44006382843792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48681,-0.00356577383163576,0.035718181317511,-0.0735734092139574,0.0664418615506859,0.920479669296536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48681,0.0549912552801105,0.0359728271191034,-0.0155154858733322,0.125497996433553,0.126357379152448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48681,-0.00123977752913974,0.020476989808565,-0.0413746775539271,0.0388951224956477,0.951722249993577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,35799,-0.115908672764453,0.0383816197381061,-0.191136647451141,-0.0406806980777652,0.00253744568790265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,35799,-0.115546371256508,0.0365005701018316,-0.187087488656098,-0.044005253856918,0.00155406324200762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,35799,0.0594757155789432,0.0529958230057945,-0.0443960975124139,0.1633475286703,0.261784338113231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,35799,0.051361850079582,0.0392216455482069,-0.0255125751949035,0.128236275354067,0.190397289297381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48640,-0.0110647784755907,0.0716522579775323,-0.151503204111554,0.129373647160373,0.877277534518734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48640,0.0225421972569453,0.0887050148629353,-0.151319631874408,0.196404026388298,0.799401289337495
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48640,-0.110666604277773,0.168125975547322,-0.440193516350524,0.218860307794979,0.510393924564582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48640,0.112430115745389,0.162217754921006,-0.205516683899783,0.430376915390561,0.488266474198448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48640,0.0701057449607484,0.0671164102468217,-0.0614424191230223,0.201653909044519,0.296248430168751
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48640,0.0754474591100364,0.0783778000714952,-0.0781730290300942,0.229067947250167,0.335753579083443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48640,0.00139008331911883,0.0334520696559781,-0.0641759732065982,0.0669561398448359,0.966854276504282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34633,-0.000715667840583098,0.0578355240987672,-0.114073295074167,0.112641959393001,0.990127484902946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34633,-0.0156844758966516,0.056063666227821,-0.125569261703181,0.0942003099098775,0.77966980097052
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34633,0.0201179466120497,0.0814866569318713,-0.139595900974418,0.179831794198518,0.805004549395364
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34633,0.0359462664401549,0.0290976310319792,-0.0210850903825243,0.0929776232628342,0.216741883100535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37304,-0.0775412470135542,0.0245775373345003,-0.125713220189175,-0.0293692738379336,0.00161064515129004
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37304,0.0447099221334407,0.0270576639923012,-0.00832309929146956,0.097742943558351,0.0984903224850792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37304,0.0753997446019745,0.024014386225924,0.0283315475991634,0.122467941604786,0.00169643890846194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37305,-0.0242860345566224,0.0561175734408464,-0.134276478500681,0.0857044093874365,0.665192173128181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37305,0.00404867880564404,0.0333896918204462,-0.0613951171624304,0.0694924747737185,0.903491582312207
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37305,-0.0318893202712635,0.0609295567498403,-0.151311251500951,0.0875326109584235,0.600723060499197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48681,0.035501037203102,0.052519132612523,-0.0674364627174431,0.138438537123647,0.499071356007702
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48681,0.008727288815704,0.0421413539518821,-0.0738697649299848,0.0913243425613928,0.835937301223572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48681,-0.12838069756685,0.087440021984686,-0.299763140656834,0.0430017455231346,0.142061662680989
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48681,-0.00829583541905701,0.0471823861240132,-0.100773312222123,0.0841816413840089,0.860433328228728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48681,0.0423359110864461,0.0484089078543353,-0.052545548308051,0.137217370480943,0.381830378848316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48681,-0.00693147263897629,0.0586111422652012,-0.121809311478771,0.107946366200818,0.905861225099602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48681,-0.0313535123736677,0.0170073299243398,-0.0646878790253736,0.00198085427803825,0.0652664816766497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33381,0.00805472956576975,0.0416883131499661,-0.0736543642081638,0.0897638233397033,0.846800261641
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33381,-0.058543082596314,0.0502882036844545,-0.157107961817845,0.0400217966252169,0.244420751729716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33381,-0.0412805771159034,0.0374119480450014,-0.114607995284106,0.0320468410522994,0.26990631991241
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33381,0.01282166667885,0.0334865339897259,-0.0528119399410127,0.0784552732987127,0.701818177856354
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48770,0.0527501404802562,0.0206237967417071,0.0123274988665102,0.0931727820940021,0.0105429762101068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48770,0.174445615774325,0.0676904048086368,0.0417724223493969,0.307118809199253,0.0099700620273609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48770,-0.0290635553205846,0.01818304514706,-0.0647023238088222,0.00657521316765301,0.109972388876034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48770,-0.0123772358187023,0.0170063847155008,-0.0457097498610838,0.0209552782236793,0.466744867930923
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48770,0.0420630695593895,0.0290830410163267,-0.0149396908326108,0.0990658299513898,0.148106037286802
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48770,0.0111790116651834,0.0258804191285552,-0.0395466098267847,0.0619046331571515,0.665783364371348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48770,-0.00854971324683419,0.018379250891394,-0.0445730449939665,0.0274736185002981,0.641805504694474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48770,-0.00511677981219846,0.0599507006368733,-0.12262015306047,0.112386593436073,0.931984154970667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42628,-0.0271738643564429,0.0188584312984279,-0.0641363897013616,0.0097886609884758,0.149624008503283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42628,-0.00191847419176179,0.0185870351209694,-0.0383490630288618,0.0345121146453382,0.9177932401031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42628,-0.0104716710927356,0.0239731423334092,-0.0574590300662177,0.0365156878807465,0.66225699514281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42629,-0.00915168952436929,0.0372793026325918,-0.0822191226842491,0.0639157436355105,0.806080775684393
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42629,0.0337617129195808,0.0212523957741907,-0.00789298279783301,0.0754164086369946,0.112171594137804
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48582,-0.00688603067732689,0.0195589939033714,-0.0452216587279349,0.0314495973732811,0.724793478395922
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48582,-0.0100986781197791,0.0153682418032659,-0.0402204320541802,0.0200230758146221,0.511115550848565
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48582,0.0247393326814072,0.0173635464094102,-0.00929321828103688,0.0587718836438513,0.15423477399448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48582,0.0464868075074946,0.0265480628190587,-0.00554739561786034,0.0985210106328496,0.0799537950671902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48600,0.0141430759950588,0.0165156878724133,-0.0182276722348714,0.0465138242249889,0.391818935599058
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48600,-0.00550062896948911,0.0230853674884639,-0.0507479492468783,0.0397466913079001,0.811671493135799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48681,0.0323009336197861,0.0168837811971807,-0.00079127752668795,0.0653931447662602,0.0557451227694788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48681,0.0216491604008868,0.0212164049262526,-0.0199349932545684,0.0632333140563419,0.3075524091513
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48681,-0.0272211051418752,0.0447286322640732,-0.114889224379459,0.0604470140957082,0.542807463731849
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48681,-0.0244468181440468,0.0417981999132649,-0.106371289974046,0.0574776536859524,0.558636797035039
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48681,0.0765641642012224,0.0504000608087294,-0.0222199549838872,0.175348283386332,0.128745920370266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48681,0.068864128608304,0.0511836452233793,-0.0314558160295194,0.169184073246127,0.178500867814964
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39925,-0.0106028923132612,0.0102406429405846,-0.030674552476807,0.00946876785028457,0.300516533217234
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,48373,0.00236603564318448,0.0121592812649398,-0.0214661556360975,0.0261982269224665,0.845718436575148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X874.Duration of walks,46104,-0.00906535859313482,0.00792334890105511,-0.0245951224392028,0.00646440525293319,0.252584461938519
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47845,0.0180813915388112,0.0117398834221254,-0.0049287799685546,0.041091563046177,0.123535879637717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X894.Duration of moderate activity,43759,-0.00106071241457778,0.0140417025895095,-0.0285824494900165,0.0264610246608609,0.939785945212888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,32540,0.0115610744396161,0.0182942308979889,-0.0242956181204422,0.0474177669996744,0.527454957165327
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47782,0.00262576286026924,0.0119152589303426,-0.0207281446432022,0.0259796703637407,0.825585533359914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Physical activities,X914.Duration of vigorous activity,40078,-0.00523638868265596,0.00960193963131198,-0.0240561903600274,0.0135834129947155,0.585525502264626
